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Introduction 1 
1. Background of the study and problem statement 
 
366 million people were affected by the metabolic disease diabetes mellitus in 2011 
and there is an expected increase to 552 million until 2030 [1]. A precise and a easy 
control of the blood glucose level are prerequisites for diabetes patients to avoid long 
term effects through hyperglycemia or life threatening hypoglycemia during insulin 
application. 
The most common glucose determination systems patient self-monitoring follow the 
principle of electrochemical biosensors (see chapter 1.4). Different sensors have 
been developed for glucose sensing based on enzymatic (e.g. through 
oxidireductases) and non-enzymatic recognition systems (e.g. platinum or non-
catalytic binding proteins) [2-8]. The most common systems in diabetes care are 
amperometric measurement setups employing either Glucose oxidases (GOx’s) or 
Glucose dehydrogenases (GDH’s) for biological recognition [3, 9].  
One major challenge in diabetes care is the development of specific systems which 
show no interferences by components of the investigated blood sample or the 
measurement environment. On one hand the GOx’s are highly specific for β-D-
glucose [10, 11] but naturally accept molecular oxygen as an electron acceptor. This 
leads to competitive electron shuttling between the employed mediators in 
electrochemical sensors and the molecular oxygen in the blood sample [12-15]. This 
oxygen activity of GOx might lead to an underestimation of the glucose level [16, 17] 
what is crucial for pO2 levels > 100 Torr. Oxygen effects, caused by the oxygen 
dependency of GOx, can be relevant for critically ill patients [18-20]. 
On the other hand GDHs do not accept molecular oxygen as an electron acceptor but 
can convert different clinical relevant sugars like galactose, maltose and xylose to an 
analytical relevant extent [21, 22]. This for instance plays an important role for 
dialysis patients during Icodextrin administration. Icodextrin is a corn starch derived 
high molecular polymer which is used as an osmotic agent during peritoneal dialysis 
[23]. The polymer is metabolized after absorption from the peritoneal cavity yielding 
in an average serum concentration of 300 mg/dL (concentration of maltose, 
maltotriose and maltotetraose) [24-29]. 
Both, the GOx and the GDH, have been extensively reengineered in order to design 
enzymes which meet the desired properties for specific applications in β-D-glucose 
sensing. In terms of high β-D-glucose specificity, pyrrolochinolinchinon depending 
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GDH (GDH-PQQ) were engineered for less maltose activity (50-times reduced 
maltose activity) [30, 31]. Alternatively, flavin adenine dinucleotide (FAD) dependent 
GDH’s were introduced for their application in glucose sensing which exhibit a 
residual activity for maltose of about 0.3 % [32-35].  
GOx was mainly engineered to increase activity and / or stability [36-40]. Two reports 
describe reengineered GOx’s for mediated electron transfer. In report one 
ferrocenemethanol was used as a mediator component in a directed evolution 
campaign resulting variant T30V-I94V which exhibits a two-fold increased kcat-value 
(69.5/s WT; 137.7/s T30V-I94V) as well as a slightly increased thermal resistance 
and a shifted pH-activity profile [40]. In report two Horaguchi et al. employed 
phenazine methosulfate as an electron acceptor in a rational protein engineering 
approach. This approach delivered a variant of the GOx from Penicillium 
amagasakiense with a 11-fold higher dehydrogenase/oxidase ratio and a GOx 
variant of the GOx from Aspergillus niger with a 6-fold higher dehydrogenase / 
oxidase ratio [41]. None of the latter two reports describe a system in which a 
diabetes care relevant mediator system was used. 
 
1.2 Objectives and project overview 
 
The aim of the present work was to reengineer Glucose oxidase (GOx) from 
Aspergillus niger for less oxygen dependency and for improved acceptance of 
artificial mediators for applications in diabetes care. Thereby, the focus was to 
develop a GOx, suitable for oxygen inference free β-D-glucose sensing while 
maintaining the high β-D-glucose specificity and thermal stability. Furthermore, the 
electron transfer mechanism from the active site via oxygen and artificial mediator 
systems was investigated and described. 
The project was divided in three parts. In the first part (chapter 3) a suitable 
screening system for GOx engineering was established for the selection of GOx 
variants with the desired properties. The screening compounded of two different 
assays. The ABTS-assay was employed to detect reduced oxygen dependent 
variants and a quinone diimine mediator assay (QDM-1 assay) was employed to 
detect improved mediator activity. The quinone diimine mediator system was 
selected due to its low interferences with blood components and its high importance 
in diabetes care [3]. In the following, the aim was the identification of amino acid 
residues which contribute to the reduction of the oxygen dependency and the 
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increase of the mediator activity applying random mutagenesis. Moreover, identified 
“hot-spots” were investigated by focused site saturation to assess their impact on the 
change of the GOx properties and to identify the ideal occupation for each amino 
acid residue. Cooperative effects along the identified amino acid positions were 
addressed by simultaneous site saturation. A final variant was subjected to 
characterization studies regarding oxygen independency, mediator activity, specificity 
and stability. The first part was finalized by the implementation of computational 
studies (by the subgroup for computational biology) for an assessment of the 
experimental results and to describe a model for an oxygen independent GOx. 
The results of the first project part were taken as a basis for studies of the mediator 
mechanism in part two (chapter 4). Therefore, the binding of two different quinone 
diimine mediator systems and ferrocenemethanol was assessed by site directed 
mutagenesis, variant characterization and computational analysis. 
In order to ensure a reproductive supply of purified GOx for the characterization 
studies of selected variants from thesis part one and two, an establishment of a GOx 
production process was implemented within the third project part (chapter 5). The up-
stream process development was based on the hypo-glycosylating Saccharomyces 
cerevisiae ngd29 strain [42]. The Sc ngd29 generates a homogeneous hypo-
glycosylation pattern what ensures comparability between different experiments and 
between different variants. The development of the down-stream process was based 
on reported protocols from Ziwei Zhu [39, 40, 43] including ion-exchange 
chromatography, hydrophobic interaction chromatography as well as gel filtration. 
The development focused on the performance optimization of the liquid-
chromatography steps, the up-scaling and the establishment of tangential-flow 
filtration in order to achieve a quick and simple protocol with the possibility for large 
volume handling at pilot scale. 
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1.3 Glucose oxidase (GOx) 
 
1.3.1 Structural insights / reaction mechanism 
 
Glucose oxidase (β-D-glucose: oxygen 1-oxidoreductase) is a flavoprotein which has 
mainly been isolated from the genus Aspergillus and Penicillium whereby the best in 
literature described GOx is from Aspergillus. niger [44-49]. GOx from A. niger is a 
homodimeric glycoprotein with an average molecular weight of 186 kDa, depending 
on the carbohydrate content [49]. The carbohydrate content varies from 10 -16 % [50, 
51]. The force for dimer formation is provided by strong hydrogen bonds and salt 
bridges within a narrow but long contact area [52, 53]. Each monomer carries one 
molecule of the noncovalently bound redox cofactor flavin adenine dinucleotide 
(FAD) [54]. The dimer formation and FAD binding are coupled by the formation of a 
lid structure in the dimer interface (Fig. 1-1-a). This lid structure covers a FAD binding 
channel and is partially buried within the formed dimer preventing the opening of lid 
[52, 53]. 
 
 
Figure 1-1: Representation of GOx from A. niger based on the x-ray structure 1cf3 [53]. a): GOx-
dimer; b): Active site enlargement. H516 and H559 are highlighted as catalytic active residues along 
with FAD in the active site. Green solid ribbon: surface lid structure in the dimer interface. Ribbon 
representation was prepared using the Discovery Studio software package [55]. 
 
The reaction kinetics of GOx follows the Ping Pong Bi Bi mechanism [56] and the 
catalysis may be divided in two steps. In step one the enzyme catalyzes the oxidation 
of β-D-glucose to D-glucono-δ-lactone whereby the cofactor FAD is reduced to 
FADH- [57]. To step one of the reaction is often referred as reductive half reaction of  
a) b)
H559
H516
FAD
Lid 
structure
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the enzyme. In step two molecular oxygen acts as an electron acceptor and the 
reduced cofactor is re-oxidized resulting in hydrogen peroxide formation, often 
referred to as oxidative half reaction [14] (Fig. 1-2).  
 
 
 
Figure 1-2: Representation of the GOx reaction cycle. Reductive half reaction: oxidation of glucose to 
gluconolactone, reduction of FAD to FADH
-
. Oxidative half reaction: oxidation of FADH
-
 to FAD by 
oxygen, formation of H2O2 [57]. 
 
 
The N5 of the isoalloxazine ring of the FAD represents the catalytic center of the 
Enzyme [14] which is accessible through a funnel shaped pocket that is formed from 
the surface lid structure (residues 75 to 98) into the active site [52]. The catalytic 
active residues His 516 and His 559 are located in close vicinity to the active center 
(Fig. 1-1-a).  
The GOx reaction mechanism was studied intensively [56, 58-60] and reviewed by 
Leskovac et al. [57]. A hydride abstraction mechanism has been proposed to be most 
likely for the reductive half reaction of GOx [57]. In the oxidative half reaction the re-
oxidation of the FADH- to FAD takes place by the reduction of dioxygen to hydrogen 
peroxide via two single electron transfer steps [57]. Not all terms of the oxidative half 
reaction are well understood yet. 
 
 
 
1.3.2 Substrates of Glucose oxidase 
 
The substrates of GOx can be divided into two groups, the electron donor substrates 
of the reductive half reaction and the electron acceptor substrates of the oxidative 
half reaction. Table 1-1 shows an overview of possible substrates for the reductive 
half reaction.  
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Table1-1: Electron-donor substrates of GOx. Modified after Lescovac et al., 2005 [57]. 
Substrate Relative to 
glucose 
(%)
a
 
Source  Substrate Relative to 
glucose 
(%)
a
 
Source 
β-D-Glucose 100 [14, 15, 
56, 61-63] 
 3-Deoxy-D-glucose 1 [15] 
2-Deoxy-D-glucose 25-30 [15, 61, 
62] 
 6-O-methyl-D-glucose 1 [15] 
4-O-methyl-D-glucose 15 [15]  α-D-Glucose 0.64 [15, 61] 
6-Deoxy-D-glucose 10 [15]  Mannose 0.2; 1 [15, 61, 
62] 
4-Deoxy-D-glucose 2 [15]  Altrose 0.16 [15, 61] 
2-Deoxy-6-fluoro-D-
glucose 
1.85 [61]  Galactose 0.08 [15, 61, 
62] 
3,6-Methyl-D-glucose 1.85 [61]  Xylose 0.03 [15, 61, 
62] 
4,6-Methyl-D-glucose 1.22 [61]  Idose 0.02 [15, 61] 
a
 Activity relative to β-D-Glucose in percentage. 
 
Table 1-1 shows that GOx accepts next to β-D-glucose a variety of substrates, but β-
D-glucose is by far the best. Even though GOx utilizes molecular oxygen as a natural 
electron acceptor the electron transfer from the enzyme to electrodes or redox 
indicators is described for several mediator compounds which incorporate GOx as 
examples given in Table 1-2. 
 
Table1-2: Overview of mediator compounds which can incorporate GOx. Table modified after Harper 
et al., 2010 [64]. 
Mediator / Mediator system Reference 
Benzyl viologen [65] 
Indigo disulfonate [65] 
Methylene blue [66] 
2,5-dihydroxybenzoquinone [66] 
Phenazine methosulfate [41] 
Ferrocenemethanol [39, 43] 
Quinone diimine / phenylenediamine [3, 67-69] 
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The high specificity of GOx for β-D-glucose and the acceptance of artificial electron 
acceptors is a prerequisite to employ GOx for accurate diabetes analytics. 
 
1.4 Enzymes in blood glucose meters 
 
Easy to handle self-measurement devices, which work reliably at all live situations 
and deliver a real time blood-glucose value are crucial for keeping diabetes patients 
close to a high quality of living. The development of pocket suitable devices, which 
work highly accurate and provide the blood-glucose concentration directly in a digital 
form was the main challenge in the last 40 years [3]. Self-measurement of blood-
glucose started around 1970. The Chemstrip bG® from Boehringer Mannheim was a 
typical system produced in 1975. This system worked with a test stripe designed for 
visual determination of glucose by the patient. A large drop of blood (25 µL) had to be 
placed on the test stripe by the patient. After a defined measurement interval of 1 
min, the blood was manually wiped off, and after a further minute, the color of the 
chemistry pad hat to be compared with a printed color scale [3]. Modern systems 
need around 1 µL per measurement. 
Most of current glucose determination systems for the patient self-monitoring are 
based on the principle of electrochemical biosensors [3] [9, 70, 71]. Typical 
biosensors consist of two main components. Component one is the biological 
recognition system which translates information from a biochemical event into a 
measurable output signal depending on the concentration of the analyte. This output 
signal can be of chemical or physical nature [71]. The main purpose of the biological 
recognition is the generation of an analyte-specific signal. The recognition can either 
be specific for a single analyte or an analyte group. The second component is the 
transducer. The transducer transfers the output signal from the recognition system to 
the electrical domain; thereby a non-electrical signal is transduced to an electrical 
signal [71].  
Different sensors have been developed for glucose sensing based on enzymatic- 
(e.g. through oxidireductases) and non-enzymatic recognition systems (e.g. platinum 
or non-catalytic binding proteins) [2-8]. The most common systems in diabetes care 
are amperometric measurement setups employing either Glucose oxidases (GOx’s) 
or Glucose dehydrogenases (GDH’s) for the biological recognition [3, 9]. In the latter 
system electrons are transferred from the redox center of the GOx or the GDH to a 
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counter electrode employing mediator compounds or mediator cascade systems. The 
resulting electron flux is thereby proportional to the glucose concentration in the 
investigated blood sample [70]. Table 1.3 shows a selection of enzymes -mediator 
couples which are employed in blood-glucose sensors.  
 
Table1- 3: Enzyme / mediator systems employed in blood-glucose sensors [3]. GOD: Glucose 
oxidase; GDH: Glucose dehydrogenase; PQQ: pyrrolo quinoline quinone; POD: peroxidase; FAD: 
flavin adenine dinucleotide; NAD: nicotinamide adenine dinucleotide; GucDOR: glucose dye 
oxidoreductase. 
 
 
A common system in diabetes care is the Accu-Chek Aviva system from Roche, 
which applies a PQQ dependent Glucose dehydrogenase (GlucDOR) in combination 
with a Quinone diimine / phenylenediamine mediator system for mediated electron 
transfer [3, 68, 72]. 
 
1.4.1 Quinone diimine / phenylenediamine mediator systems 
 
Requirements of mediator systems for blood glucose monitoring are efficient electron 
transfer rates, low unspecific interactions with blood components and high storage 
stabilities when immobilized on glucose test stripes. These properties are given for 
quinone diimine / phenylenediamine mediator systems which are employed in blood-
glucose meters [3]. Low unspecific interactions of this system can be attributed to low 
redox potentials and to a specific mediator chemistry. Additionally, quinone diimines 
feature a high stability when immobilized in form of N-substituted p-nitrosoanilin, a 
storage stable precompound of the corresponding quinone diimine [3, 68, 69]. Figure 
1-3 shows the structure of two N-substituted p-nitrosoanilines which are Roche 
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internally used for glucose determination assays and which were also selected as 
mediator systems for the present investigations. 
 
 
Figure 1-3: N-substituted p-nitrosoanilines BM 31.1008 and BM 31.1144. Nitrosoanilines are storage 
stable precompounds of the quinone diimines which are used as electron mediators in glucose 
sensing. BM 31.1008: N,N-bis(2-hydroxyethyl)-4-nitrosoaniline; BM 31.1144: N,N-bis(2-hydroxyethyl)-
2-methoxy-4-nitrosoaniline. 
 
BM 31.1008 is a Roche internal designation for N,N-bis(2-hydroxyethyl)-4-
nitrosoaniline and BM 31.1144 for N,N-bis(2-hydroxyethyl)-2-methoxy-4-
nitrosoaniline. BM 31.1144 carries an additional methoxy group which makes the 
mediator more polar and more soluble in aqueous solutions. 
A commonly used blood glucose determination system is the Accu-Chek Aviva from 
Roche, which applies a quinone diimine / phenylenediamine mediator system in 
combination with a PQQ dependent Glucose dehydrogenase (GlucDOR) [3]. Fig. 1-4 
shows the reaction principle for the latter system. Like for the GOx, the reaction 
mechanism of the GlucDOR can be divided in two half reactions, the reductive half 
reaction and the oxidative half reaction. In this system the GlucDOR oxidize β-D-
glucose to gluconolactone by simultaneous reduction of the cofactor PQQ (reductive 
half reaction). The N-substituted p-nitrosoaniline is reduced to the corresponding 
chinondiimine via hydroxylamine in the oxidative half reaction of GlucDOR. The 
chinondiimine act as the actual mediator for the electron transfer and it is converted 
in the oxidative half reaction of enzyme to phenylendiamine. Two electrons come out 
of the spontaneous nonenzymatic back reaction of phenylendiamine to 
chinondiimine. Those two electrons get indicated amperometric using an electrode 
system, or photometric using a redox indicator dye [3, 68, 69]. 
  
BM 31.1008 BM 31.1144
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Figure 1-4: principle of mediated electron transfer employing a quinone diimine / phenylenediamine 
mediator system. Two enzymatic conversions are involved in the mediuated electron transfer. In the 
first conversion the N-substituted nitrosoaniline is converted to chinondiimine (the actual mediator 
compound) via hydroxylamine. Subsequently the chinonediimine is is converted to phenylendiamine. 
Two electrons than are donated during the spontaneous back reaction to chinondiimine. The recycled 
chinondiimine is than available for the next conversion. GlucDOR: Glucose-Dye-Oxidoreduktase; 
PQQ: pyrrolo quinolone quinone. 
 
The described mechanism is also applicable for GOx, but in contrast to the oxygen 
independent GlucDOR, GOx will simultaneously use molecular oxygen as an electron 
acceptor as described in chapter 1.3.1. The reaction principle for the GOx - Quinone 
diimine / phenylenediamine mediator assay for mutant library screening is shown in 
chapter 3.3.1.1.  
 
1.5 Directed protein evolution  
 
Proteins are bio molecules which are of great interest for industrial applications, for 
instance as drug substances in medicine, as chemical reagents, for molecular 
recognition in diagnostics or as food additive. Thereby the protein can act as 
structural molecule (e.g. as antibody, antigen or nutrient) or the protein is able to 
catalyze biochemical reactions as an Enzyme which feature a high substrate 
specificity and high conversion rates under moderate conditions. Enzymes are 
usually isolated from natural sources where they work under specific conditions with 
p-Nitrosoaniline
Hydroxylamine
GlucDOR-PQQH2
GlucDOR-PQQ
Glucose
Gluconolactone
2 H+
H2O
Chinondiimine
GlucDOR-PQQH2GlucDOR-PQQ
GluconolactoneGlucose
Phenylendiamine
2 e-
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respect to temperature, pH-value, ionic strength and they mostly work in aqueous 
environment. For industrial applications enzymes often need to be optimized to fulfill 
the requirements for a specific application. The optimization may affect the enzymatic 
activity under selected conditions, the biochemical reaction itself (e.g. selectivity) or 
enzyme stability. Protein engineering gives the opportunity to adapt proteins to 
specific requirements and to design high effective processes, analytical tools and 
drug products based on renewable molecules. The most common strategies for 
protein engineering are rational design and directed evolution [73]. 
Rational design is based on fundamental knowledge of the protein structure and 
function and the relationship between the sequence the structure and the function. 
Furthermore, a certain computational power is necessary for the experimental design 
and the assessment of results by molecular modeling. However, rational design 
requires a less intensive laboratory setup since preferred engineering methods are 
site-directed mutagenesis and site-saturation mutagenesis.  
In contrast, directed evolution does not require as much pre-knowledge and 
computational power as a rational design approach, but requires an enormous 
laboratory effort. Directed evolution is based on the selection of proteins with the best 
properties out of a diverse population, but it significant differs from the natural 
Darwinian evolution since it requires a laboratory screening- or selection system to 
direct the evolution in terms of the desired conditions [74]. In the last years an 
increasing number of success stories were observed for improved proteins for 
industrial applications by directed evolution ranging from biotransformation in 
chemical synthesis, hydrolysis in detergents, molecular recognitions in biosensors to 
medical applications [67, 75-79]. A classical experiment combines methods of 
molecular biology, biochemistry and bio-processing and can be divided in three major 
steps: gene diversity generation, screening for improved variants and gene isolation 
(Figure 1-5).  
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Figure 1-5: Scheme of a directed evolution experiment with iterative cycles. The experimental setup 
consist of three major steps: 1. Gene diversity generation; 2. Screening for improved variants; 3. Gene 
isolation [80]. 
 
Fundamental challenges in directed evolution are the unbiased generation of 
diversity and the screening of gene libraries of a statistical relevant size under 
conditions close to those of the final application. Both aspects will be discussed in the 
following paragraphs. Furthermore, it is important to notice that the success of a 
directed evolution campaign also depends on a suitable and detailed characterization 
of selected protein variants, wherefore the development of up- and down-stream 
protocols are often necessary. 
 
1.5.1 Diversity generation 
 
The success of a directed evolution campaign strongly depends on the ability to 
generate gene libraries of a sufficient size and more important a sufficient diversity. 
Gene recombination and random mutagenesis are two general principles which have 
been established [81]. In gene recombination beneficial mutations can be 
accumulated and unfavorable ones eliminated. Therefore, recombination techniques 
find their application if several related proteins are known or in late states of directed 
evolution campaigns. Common recombination methods are DNA shuffling and the 
staggered extension process [82, 83]. 
“The estimative goal for any random mutagenesis method is to replace any amino 
acid of a polypeptide chain by the other 19 amino acids in a statistical manner without 
limiting protein expression in the host organism” [84]. Different methods for random 
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mutagenesis have been developed [85, 86] whereby the generation of unbiased 
mutational spectra, consecutive nucleotide substitutions and independency of gene 
lengths outline the biggest challenges in the method development [84]. Wong et al. 
2006 give an detailed overview about the diversity challenge in directed protein 
evolution including a classification and summary of random mutagenesis methods 
[84]. Two frequently used methods are the error prone polymerase chain reaction 
(epPCR) [87] and the sequence saturation mutagenesis (SeSaM) [88]. The epPCR is 
a rapid, simple and robust low fidelity method which is usually based on the 
polymerase from Thermus aquatcus (Taq polymerase). The Taq DNA polymerase 
misses a 3’-5’ proofreading exonuclease function [89] and shows a substitution error 
rate of around 10-5 mutation/bp/duplication depending on the PCR conditions and the 
amplified gene [90]. To reach mutations rates high enough to perform an efficient 
directed evolution experiment the PCR-fidelity can be modified for instance by adding 
MnCl2, unbalanced nucleotide concentrations or number of PCR-cycles [87]. 
Alternatively, the mutation frequency can be increased by use of engineered 
polymerases with increased inaccuracy [91]. However, the mutational spectra of 
polymerases are highly biased and especially transversions ((AC, TG); (GC, 
CG)) are highly underrepresented and subsequent mutations are rarely observed 
(reviewed by Wong et al. 2006) [84]. SeSaM was introduced in 2004 [88] and 
overcomes the main limitations of epPCR by an un-biased mutational spectra, a 
homogenous distribution of mutations over the gene and the ability to introduce 
subsequent mutations. A SeSaM-protocol comprises four steps: 1) generation of a 
DNA-fragment pool with random size distribution; 2) enzymatic fragment elongation 
with universal bases; 3) full-length gene synthesis; 4) universal base replacement 
[88]. The SeSaM-technology was continuously improved towards a transversion-
enriched bias and the introduction of consecutive mutations [85, 92] and was 
successfully applied in several directed evolution campaigns [67, 78, 93].  
 
1.5.2 Screening of mutant libraries 
 
The selection of desirable proteins out of a diverse mutant library is another 
challenging step in directed protein evolution. The screening system needs to be 
designed in a way that the screening conditions are very close to the conditions of 
the intended application in order to identify variants that exhibit all necessary 
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properties. The screening of the mutant library takes place on the level of mature 
protein after in-vivo or in-vitro expression. Available technologies to identify beneficial 
variants can be divided into selection and screening [94]. The selection is based on 
the advantage a host cell achieves during expression of the protein of interest, so 
that only cells producing an improved protein will be selected. Prerequisite for the 
selection is the ability to detect an improved protein, most easily by a change in 
growth through a change in the phenotype. The screening might be divided in agar 
plate screening, microtiter plate screening, cell-in-droplet screen, cell as 
microreactor, cell surface display, in-vitro compartementalization [94]. Agar plate 
screening is based on the change of the host cell phenotype caused by the 
expression of the protein of interest, like for selection methods. This change of the 
phenotype can be used to detect whether the host cell expresses the protein of 
interest after cell transformation, or it can be used to screen for host cells which 
express already an improved variant. Prerequisite for agar plate screening is also the 
ability to detect the change in phenotype. A prominent example is the skim milk 
detection system to detect proteolytic activity of proteases on agar plates, where a 
clearance around colonies is observed [78, 95]. The most common used screening 
systems are indeed the microtiter plate (MTP) based systems. In MTP based 
screenings the cell clones are usually cultivated in MTP’s after transformation and 
subsequently the cell supernatants or cell lysates are transferred to a second plate 
for the performance of the screening assay. A great variety of analytical methods (like 
UV/VIS or fluorescence spectroscopy) can be applied in MTP’s and they show the 
least limitation in the dynamic range compared to the mentioned screening platforms. 
Challenges are the homogeneous cultivation over a whole plate to achieve 
acceptable standard deviations and also the accurate handling of the liquids. 
Screening capacities of MTP based systems are limited to few thousand variants a 
day, what outlines the biggest limitation of MTP based screening systems. In 
compare, cell-in-droplet screenings, cell as microreactor, cell surface display and in 
vitro compatimentalization show screening capacities of around 1010 variants but all 
require the availability of fluorescence detection systems [94]. 
Several screening systems are described for the engineering of GOx, based on 
microtiter plates as well as on fluorescence activated flow cytometric sorting [36-41, 
67, 96]. Most of the GOx-systems rely on the reduction of molecular oxygen to 
hydrogen peroxide. Only two reports refer to the use of electron mediator systems 
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[40, 41]. Zuh et al. 2007 employed ferrocnemethanol as a mediator to evolve GOx for 
bio-fuel cells and Horaguchi et al. 2012 employed phenazine methosulfate as a 
mediator to develop a GOx with reduced oxidase activity. Within the present 
dissertation the well-known 2,2′‐azino‐bis(3‐ethylbenz‐thiazoline‐6‐sulfonic acid) 
(ABTS) –assay [39, 97] was employed to detect the oxidase activity of GOx and a 
phenylendiamine/chinonediimine based assay was employed for the specific 
detection of the mediated electron transfer. The phenylendiamine/chinonediimine 
based mediators are introduced in chapter 1.4.1 and the establishment of the 
mediator assay in chapter 3.3.1. 
 
1.6 The Saccharomyces cerevisiae strain ngd29 
 
The selection of a suitable host organism is a crucial step in the planning of a 
heterologous gene expression experiment. A large variety of host organisms are 
described for the production of recombinant proteins with Escherichia coli as the 
most prominent example [98]. For a directed protein evolution campaign the selection 
of the host organism depends on the ability to cultivate the organism in multi-well 
plates, the desired cultivation time, the expression level, the ability of protein 
secretion, but it may also depends on post-translational modifications. A. Pourmir and 
T. W. Johannes 2012 give a detailed overview of the employment of different host 
organism in directed protein evolution [99]. GOx from A. niger is a homodimeric 
glycoprotein whose N-glycosylation structures are involved in the stabilization of the 
protein-dimer [52, 53] (see chapter 1.3). Saccharomyces cerevisiae is one organism 
which is described to be a suitable host for GOx expression and was already 
successfully employed in directed evolution of GOx [39, 40, 42]. Outer chain 
glycosylation in S. cerevisiae leads to a heterogeneous hyper-glycosylation pattern of 
the type [Man]n[GlcNac]2 on secreted glycoproteins [100]. Lehle et al. published in 
1995 the glycol-engineered S. cerevisiae strain ngd29 which is not able to transfer 
mannose from GDPmannose to the asparagine linked core-structure 
[Man8][GlcNAC2] leading to a uniform N-glycosylation of the structure 
[Man8][GlcNAC2] of secreted glycoproteins [42]. The ngd29 mutant was chosen for 
the directed evolution of GOx for diabetes analytics in order to achieve GOx-
molecules with a homogenous hypo-glycosylation pattern. 
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2 Materials and Methods 
 
2.1  Materials 
 
All chemicals were of analytical grade and purchased from Sigma-Aldrich 
(Taufkirchen, Germany), Applichem (Darmstadt, Germany) or Carl Roth (Karlsruhe, 
Germany). All enzymes were purchased from New England Biolabs (UK) and Sigma-
Aldrich (Taufkirchen, Germany). The pYES2 shuttle vector, the Saccharomyces 
cerevisiae INV and Escherichia coli strain DH5α were purchased from Invitrogen 
(Karlsruhe, Germany). The Saccharomyces cerevisiae strain ngd29 was provided by 
Roche diagnostics [42]. Nucleotide analogues dPTPαS and dGTPαS and 
polymerases along with respective buffers (SeSaM-Taq and 3D1) were obtained from 
SeSaM Biotech GmbH (Aachen, Germany). All other nucleotides were purchased 
from Fermentas (St. Leon-Rot, Germany). DNA was quantified using a NanoDrop 
photometer (NanoDrop Technologies, Wilmington, DE, USA). Sequencing and 
Oligonucleotide synthesis was done by Eurofins MWG Operon, Ebersberg, Germany. 
The two quinone diimine based mediators QDM-1 and QDM-2 were provided by the 
collaboration partner Roche (Roche Diagnostics, Penzberg). 
 
2.2 Methods 
 
2.2.1 Individual site saturation mutagenesis 
 
For individual site saturation mutagenesis (SSM) a two-step PCR protocol has been 
followed [101]. In step one, two extension reactions are performed in separate tubes; 
one containing the forward primer and the other containing the reverse primer. In 
step two, the two reactions are mixed and a standard PRC procedure is carried out. 
The mutations were introduced through the mutagenesis primer. For the site 
saturation degenerate primers of the form NNK were used. Tab 2-1 summarizes the 
primers used for the site saturation of position 173, 332, 414 and 560. 
 
Table 2-1: Primer used for individual site saturation mutagenesis. 
Position  Sequence (5`  3`) 
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173 GGT ACT GTC CAT NNK GGA CCC CGC GAC AC 
173 GTG TCG CGG GGT CCM NNA TGG ACA GTA CC 
332 GAC CAG ACC ACC NNK ACC GTC CGC TCC C 
332 GGG AGC GGA CGG TMN NGG TGG TCT GGT C 
414 TAC TCG GAA CTC NNK CTC GAC ACT GCC 
414 GGC AGT GTC GAG MNN GAG TTC CGA GTA 
560 ATG TCG TCC CAT NNK ATG ACG GTG TTC TA 
560 TAG AAC ACC GTC ATM NNA TGG GAC GAC AT 
 
50 µl PCR reaction mixtures were prepared containing 1 ng/µl of plasmid template, 
1x Phusion buffer (New England Biolabs, Frankfurt, Germany), 1 U of Phusion 
polymerase and 300 µM dNTP’s. The reaction mixture was divided in two equal 
volumes and forward primer and reverse primer of the targeted site were added 
(reaction mixture 1: 400 nM forward primer; rection mixture 2: 400 nM reverse 
primer). The following PCR program was carried out (Tab. 2-2): 
 
Table 2-2: PCR program for individual site saturation mutagenesis. 
Step Temperature Time Cycles 
Initial denaturation 98 ˚C 45 sec 
5 
Denaturation 98 ˚C 15 sec 
Annealing 60 ˚C 30 sec 
Extension 72 ˚C 4 min 
Hold 72 ˚C -- -- 
The reaction mixture of the forward primer was mixed with the mixture of the 
respective reverse primer and the following program was started 
Denaturation 98 ˚C 15 sec 
13 Annealing 60 ˚C 30 sec 
Extension 72 ˚C 4 min 
Hold 8 ˚C -- -- 
 
4 µl of the PCR product of each reaction was loaded on the 0.8 % agarose gel. The 
residual PCR-product was purified using the NucleoSpin® Extract II – kit 
(MACHERY-NAGEL, Germany) and subjected to DpnI digestion. 
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2.2.2 Multiple site saturation 
 
For multiple site saturation mutagenesis the OmniChange protocol was applied [102]. 
The method is based on the amplification of multiple fragments employing primer with 
phosphorthioated region. The first 12 nucleotides of primers are phosphorothioated 
and the phosphorthioated region of the forward primer of one fragment is always 
complementary to the phosphorthioated region of reverse primer of the previous 
fragment. The resultant PCR product is subjected to cleavage in presence of iodine 
and ethanol under alkaline conditions. This treatment leads to the removal of 
phoshphorthioate region of the PCR product and generates complementary 
overhangs of 12 bp. After hybridization of all fragments to the full circular plasmid 
nick-repair in a suitable host organism is necessary [102]. Tab 2-3 summarizes the 
primers used for the simultaneous site saturation of position 173, 332, 414 and 560. 
 
Table 2-3: Primer used for the multiple site saturation of the GOx gen. Lower case letters indicate 
phosphorothioated bonds. 
Primer  Sequence (5`  3`) 
P1 ggtactgtccatRYTGGACCCCGCGACAC 
P2 ggtggtctggtcCTGCAGGTTCAAG 
P3 gaccagaccaccARTACCGTCCGCTCCC 
P4 gagttccgagtaCGCGACGTTGTGG 
P5 tactcggaactcNDTCTCGACACTGCC 
P6 atgggacgacatTTGCGTAGGAGG 
P7 atgtcgtcccatVYKATGACGGTGTTCTA 
P8 atggacagtaccATTAACACCATG 
 
The PCR reaction mixture was prepared as a recently reported [102]. For Fragment 1 
amplification, targeting A173, primers P1 and P2 were added in the master mix. 
While for A332 saturation, P3 and P4 were used. F414 site was targeted by using P5 
and P6. The V560 site was included in vector backbone as it was amplified by P7 
and P8. The following PCR program was carried out (Tab. 2-4): 
 
Table 2-4: PCR program of simultaneous site saturation mutagenesis. 
Step Temperature Time Cycles 
Initial denaturation 98 ˚C 45 sec 1 
Denaturation 98 ˚C 15 sec 20 
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Annealing 65 ˚C 30 sec 
Extension 72 ˚C 30 sec 
Final extension 72 ˚C 5 min -- 
Hold 8 ˚C -- -- 
 
The fragments were digested and ligated as previously reported before 
transformation of chemical competent E. coli DH5α for library amplification [102]. For 
yeast transformation the gene library was isolated from E. coli DH5α using the 
plasmid isolation kit “NucleoSpin Plasmid MACHERY-NAGEL GmbH & Co. KG 
Düren”. 
 
2.2.3 Diversity generation by epPCR 
 
Error prone PCR is the low fidelity method for the generation of random mutagenesis 
libraries. epPCR is usally based on the Taq-polymerase which misses a 3’-5’ 
proofreading exonuclease function [89]. More details about the method background 
are given in chapter 1.5.1. Tab 2-5 summarizes the primers used for the random 
mutagenesis of the GOx-gen.  
 
Table 2-5: Primer used for the random mutagenesis by epPCR. 
Primer  Sequence (5`  3`) 
P1 GTGGTCTCCCTCGCTGCGGCCCTGCCACACTACATCAGGAGCAATG
GCATTGAAGCCAG 
P2 ATTACATGATGCGGCCCTCTAGATGCATGCTCGAGCGGCCGCCAGTG
TGATGGATATCTG 
 
The PCR-mix had a total volume of 50 µL and was composed as follows: 3 ng/µL 
pDNA template, 0.2 mM dNTP mix, 0.1 mM MnCl2 for adjusting the mutation 
frequency, 10 pmol of each primer (P1 and P2) and 5 U Taq polymerase. Tab 2-6 
summarizes the PCR program which was carried out. 
 
Table 2-6: PCR program epPCR library generation. 
Step Temperature Time Cycles 
Initial denaturation 94 ˚C 2 min 1 
Denaturation 94 ˚C 1 min 30 
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Annealing 65 ˚C 1 min 
Extension 72 ˚C 2 min 25 sec 
Final extension 72 ˚C 10 min 1 
Hold 8 ˚C -- -- 
 
4 µl of the PCR product was loaded on the 0.8 % agarose gel. The residual PCR-
product was purified using the NucleoSpin® Extract II – kit (MACHERY-NAGEL, 
Germany) and subjected to DpnI digestion before cloning. 
 
2.2.4 Diversity generation by SeSaM 
 
SeSaM is an advanced PCR based mutagenesis method for the construction of 
libraries with a homogeneous mutation distribution over the gen, with the ability to 
generate subsequent mutations without a mutational bias. A SeSaM-protocol 
comprises four steps: 1) generation of a DNA-fragment pool with random size 
distribution; 2) enzymatic fragment elongation with universal bases; 3) full-length 
gene synthesis; 4) universal base replacement [88]. More details about the method 
background are given in chapter 1.5.1. Tab 2-7 summarizes the primers used for the 
SeSaM-library generation. 
 
Table 2-7: Primer used for the multiple site saturation of the GOx gen. Lower case letters indicate 
phosphorothioated bonds. 
Primer  SeSaM step Sequence (5`  3`) 
P1 1 GGC GTG AAT GTA AGC GTG ACA TA 
P2 1 CACACTACCGCACTCCGTCG CCG GAT CGG ACT 
ACT AGC AG 
P3 3 CCG GAT CGG ACT ACT AGC AG 
P4 3 GTGTGATGGCGTGAGGCAGC GGC GTG AAT GTA 
AGC GTG ACA TA 
P5 final amplification GTGGTCTCCCTCGCTGCGGCCCTGCCACACTACA
TCAGGAGCAATGGCATTGAAGCCAG 
P6 final amplification ATTACATGATGCGGCCCTCTAGATGCATGCTCGAG
CGGCCGCCAGTGTGATGGATATCTG 
 
SeSaM library generation was carried out as previously described [85]. DNA 
templates for SeSaM-TV-II-step 1 and step 2 were prepared by PCR. The 50 µL PCR 
mixture contained: 1x Phusion HF Buffer; (New England Biolabs); 0.2 mM of each 
dNTP; 12.5 pmol of each primer (forward and reverse); 2.5 U of Phusion polymerase 
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(New England Biolabs) and 50 ng of plasmid as template. Tab 2-8 summarizes the 
PCR program which was carried out. 
 
Table 2-8: PCR program for SeSaM template generation. 
Step Temperature Time Cycles 
Initial denaturation 98 ˚C 30 sec 1 
Denaturation 98˚C 10 sec 
20 Annealing 60 ˚C 30 sec 
Extension 72 ˚C 1 min 20 sec 
Final extension 72 ˚C 5 min 1 
Hold 8 ˚C -- -- 
 
The primers P1 and P2 were used for step 1 template generation and the primer P3 
and P4 for the step 3 template generation. The PCR-product of step-4 was subjected 
to a final PCR-amplification applying identical PCR-conditions as used for the 
SeSaM-Tv-II template preparation employing the primers P5 and P6. 
 
2.2.5 Gene cloning  
 
A ligation free Method was selected for the cloning of mutant libraries in the vector 
pYES2 [103]. The method is based on homologous recombination by the yeast cell 
itself. Figure 2-1 shows the principle of the cloning strategy. 
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Figure 2-1: Cloning strategy fort he directed GOx evolution based on homologous recombionation. 
The strategy consists of four steps: 1. Gene amplification and vector linearization; 2. Yeast cell 
transformation; 3. Homologous recombination. 
 
The cloning method comprises three steps: 1. the gene amplification with special 
recombination primer and the vector linearization; 2. yeast cell transformation and 3. 
homologous recombination by the yeast cell. The primers for the amplification of the 
gene of interest are designed in a way, that the primers have an at least 30 bp 
overhang complementary to the vector backbone (forward primer to the promoter, 
reverse primer to the terminator). For the transformation of the SeSaM-1 library a 
transformation efficiency of 2x104 cfu/µg has been obtained. 
The cloning of mutated GOxs into the pYES2 vector backbone was performed 
according to a recombination method [103]. Tab. 2-9 summarizes the primers used 
for the insert amplification. 
 
Table 2-9: Primer used for the insert amplification within the cloning by homologous 
recombination. 
Primer  Sequence (5`  3`) 
FWD GTGGTCTCCCTCGCTGCGGCCCTGCCACACTACA
TCAGGAGCAATGGCATTGAAGCCAG 
REV ATTACATGATGCGGCCCTCTAGATGCATGCTCGAG
CGGCCGCCAGTGTGATGGATATCTG 
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The 50 µL PCR mixture contained: 1x Phusion HF Buffer; (New England Biolabs); 
0.2 mM of each dNTP; 12.5 pmol of each primer (FWD and REV); 2.5 U of Phusion 
polymerase (New England Biolabs) and 3 ng of plasmid as template. Tab 2-10 
summarizes the PCR program which was carried out. 
 
Table 2-10: PCR program for insert amplification 
Step Temperature Time Cycles 
Initial denaturation 98 ˚C 40 sec 1 
Denaturation 98˚C 20 sec 
29 Annealing 68 ˚C 30 sec 
Extension 72 ˚C 1 min 20 sec 
Final extension 72 ˚C 5 min 1 
Hold 8 ˚C -- -- 
 
2 µg of pYES2-GOx T30V I94V were linearized by SalI/BamHI digestion (10 U/µg 
DNA, 6 h, 37°C) and subsequently purified by gel-extraction employing the 
NucleoSpin® Extract II – kit (MACHERY-NAGEL, Düren, Germany). The linearized 
pYES2-vector and the amplified gene library were mixed in a ratio of 1:3 (250 ng / 
750 ng). This DNA-mix was used for the transformation employing a lithium acetate 
method [104]. Transformants were grown on SC-U selective plates containing 2 % 
glucose. For the transformation of closed plasmids 300 ng DNA was used. To obtain 
GOx-molecules with a reduced glycosylation level the glyco-engineered S. cerevisiae 
strain ngd29 was chosen as expression host [42]. 
 
2.2.6 Cultivation in microtiter plates 
 
Single colonies were grown on SC-U selective agar plates containing 2 % glucose at 
30°C for 48 – 72 h. Subsequently, single colonies were transferred into 96-well 
microtiter plates (100 µL SC-U media; 1 % glucose; PS-F-bottom, Greiner Bio-One). 
The cultivation of the pre-culture took place in a microtiter plate shaker (900 rpm; 
30°C; 70 % humidity; 24 h; Infors GmbH, Eisenach, Germany). A certain amount of 
pre-culture was transferred to each well of a deep well plate (500 µL SC-U media; 0.5 
% glucose; 2 % galactose; riplate-rectangular, ritter). The main-culture was cultivated 
as the pre-culture with an elongated cultivation step (72 h). Cell supernatants were 
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harvested after centrifugation (3300 g; RT; 20 min) and used for activity 
determinations. For library conservation, 50 µL of the pre-cultures were transferred in 
a new microtiter-plate( PS-F-bottom, Greiner Bio-One) and 100 µL glycerol (50 % 
w/w) was added. After homogenizing of the cell-culture / glycerol mixtures the plates 
were stored at ≤-60°C. 
 
2.2.7 QDM detection system 
 
The mediators selected for the GOx evolution are based on quinone diimine sytems. 
Quinone diimines attribute efficient electron transfer rates and low unspecific 
interactions with blood components. Furthermore, they are storage stable if they are 
immobilized in form of the respective N-substituted p-nitrosoanilin, a storage stable 
precompound. The mediator system was introduced in chapter 1.4.1 and the 
mediator reaction in the QDM detection system is described in chapter 3.3.1.1. The 
term QDM-q refers to the usage of the p-nitrosoaniline (N,N-bis(2-hydroxyethyl)-4-
nitosoaniline) and the term QDM-2 to the usage of N,N-bis(2-hydroxyethyl)-2-
methoxy-4-nitrosoaniline. 
For the liquid handling multi-channel pipettes from Brand (Transferpette S-8) and 
Eppendorf (Research pro) were used. 75 µL of supernatant (see cultivation and 
expression in 96-well plates) or purified enzyme were transferred into a 96-well flat-
bottom microtiter plate (Greiner Bio-One). 100 µL of mediator solution (19.05 mM 
N,N-bis(2-hydroxyethyl)-4-nitrosoaniline [68], Roche - Material No. 100088314; 5% 
(w/w) polyvinylpyrrolidone, Roche - Material No. 10003476964; pH 7) and 20 µL of 
25 g/L phosphomolybdic acid (Roche, Genisys-nr.: 11889893001) were 
supplemented. Reactions were initiated by supplementing 25 µl substrate solution. 
The kinetic of phosphomolybdic acid reduction was monitored at 700 nm in microtiter 
plate reader (Tecan Sunrise; Tecan Trading AG, Switzerland). The amount of GOx 
that converts 1 μmol of substrate in 1 min was defined as 1 U of that enzyme.  
 
2.2.8 Thermal resistance 
 
100 µL of the enzyme solution were incubated at the corresponding temperature for 
15 min and subsequently chilled on ice for 5 min. 75 µL were used for the activity 
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determinations employing the QDM detection system. The following temperatures 
were investigated: 30-, 35-, 40-, 45-, 50-, 55-, 60-, and 65°C. 
 
2.2.9 ABTS assay 
 
The ABTS [2,2′‐azino‐bis(3‐ethylbenz‐thiazoline‐6‐sulfonic acid)]-assay is a coupled 
enzyme assay which can be applied for the activity determination of GOx. The assay 
is based on the β-D-Glucose oxidation by GOx in the present of oxygen to β-D-
Glucono-δ-lactone and H2O2. In a subsequently reaction the H2O2 and Horseradish 
peroxidase (HRP) are used to oxidize the chromogenic substrate ABTS, resulting in a 
color change of the chromogenic substrate (Fig. 3-1) [105]. 
For liquid handling multi-channel pipettes from Brand (Transferpette S-8) and 
Eppendorf (Research pro) were used. 75 µL of supernatant (see cultivation and 
expression in 96-well plates) or purified enzyme transferred to a 96-well flat-bottom 
microplate (Greiner Bio-One) containing 100 µL of phosphate buffer (0.2 M; pH 7). 20 
µL of reaction mixture were supplemented to each well resulting in final 
concentrations of 0.91 U/mL HRP and 2.3 mM ABTS. Reactions were initiated by 
supplementing 25 µl substrate solution. The oxidation of ABTS was kinetically 
determined at 414 nm using the microplate reader FLUOstar Omega (BMG 
LABTECH). The amount of GOx that converts 1 μmol of substrate in 1 min was 
defined as 1 U of that enzyme. 
 
2.2.10 Oxygen consumption assay 
 
For the direct determination of the oxygen consumption the optical oxygen probe 
“Fibox3 – Minisensor Oxygen Meter” (Precision Sensing GmbH Regensburg) was 
used. The 1540 µL reaction mixture consisted of 840 µL phosphate buffer (0.2 M / pH 
7), 175 µL Substrate solution and 525 µL GOx-solution. The oxygen consumption 
(%/min) was kinetically determined. 
 
2.2.11 Normalization of GOx concentrations employing an enzyme-linked 
immunosorbent assay (ELISA) 
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An enzyme-linked immunosorbent assay (ELISA) was used for specific determination 
of GOx concentrations, employing two GOx specific polyclonal antibodies. The 
principle of the ELISA is shown in Figure 2-2.  
 
 
Figure 2-2: Principle of specific GOx determination employing two polyclonal antibodies. a) The assay 
starts from a streptavidin coated microtiter plate. b) A polyclonal capture antibody binds specific to the 
streptavidin through covalent linked biotin. c) GOx molecules of the applied sample are recognized 
and bound by the capture antibody. d) A polyclonal detection antibody which carries a covalent linked 
horseradish peroxidase (HRP) binds specific the captured GOx. e) In the last step a H2O2/ABTS 
solution is applied. The H2O2 enzymatically converted by the HRP by simultaneous (2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid) (ABTS) -oxidation. The color change of the ABTS is 
photometric detected at 405 nm. For implementation and material information see material and 
methods section of the main article. Ab: Antibody. 
 
Each well of a streptavidin coated microtiter plate (Roche 11643673 001) was filled 
with 100 µL of a primary antibody solution (2 µg/mL; Rabbit PAK GOD-Biotin Acris 
R1083B; 1 h; RT; 400 rpm). After a subsequent washing step (4 times 350 µL 9 g/L 
NaCl_0.1 % Tween 20) 100 µL of GOx sample was transferred into each 96-well of a 
microtiter plate (1 h; RT; 400 rpm). The washing step was repeated and the 96-well 
plate was filled with 100 µL of a secondary antibody solution (10 µg/mL; Rabbit PAK 
GOD-HRP Acris R1083HRP; 1 h; RT; 400 rpm). After a third washing step the 96-
well plate was filled with 100 µL of a ABTS/H2O2 solution (11684302001 Roche 
Diagnostics GmbH Mannheim; 30 min; RT; 400 rpm), subsequently the absorption at 
405 nm was determined. Glucose oxidase from A. niger was used as internal 
standard (0.075-20 ng/mL; G7141-50KU Sigma-Aldrich). 
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2.2.12 SDS-PAGE 
 
For the protein analysis by reducing and denaturizing gel electrophoresis the 
following gel was prepared. Separating gel: 25% (v/v) acylamid (40%), 25% (v/v) 1.5 
M Tris-HCL (pH 8), 1% (v/v) sodiumdodecylsulfate (10%), 1% (v/v) 
Ammoniumpersulfate (10%), 0.04% (v/v) Temed, 48% deionized water. Stacking gel: 
12.5% (v/v) acylamid (40%), 12.5% (v/v) 1.5 M Tris-HCL (pH 6.8), 1% (v/v) 
sodiumdodecylsulfate (10%), 1% (v/v) Ammoniumpersulfate (10%), 0.1% (v/v) 
Temed, 72% deionized water. The protein samples were mixed with sample buffer 
(25 % (v/v) and subsequently boiled at 99°C for 10 min (sample buffer: 2% (w/v) 
sodiumdodecylsulfate, 0.1 % (w/v) bromphenol blue, 100 mM dithiothreitol). The 
following electrode buffer was used: 25 mM Tris, 250 mM glycin, 0.1% 
sodiumdodecylsulfate. After the prepared samples were loaded on the SDS-gel, the 
electrophoreses was performed (1 h / 150 V). For each run 5 µL of the 
PageRuler™Prestained Protein Ladder was employed. After the electrophoreses the 
gel was stained for 1 h and subsequently destained for at least 2 h (staining solution: 
0.1% coomassie brilliant blue G-250, 50% ethanol, 10% acetic acid; de-staining 
solution: 50% ethanol, 10% acetic acid). 
 
2.2.13 Cultivation of Sc ngd29 at pilot scale 
 
Pre-cultivation: 500 mL SynY media (2 % glucose) were inoculated to an OD600=0.2 
using an overnight-culture of S. cerevisiae ngd29/pYES2-GOx (overnight culture: 10 
mL YPD media, 30°C, 250 rpm, 20h); pre-cultivations took place in 5L shaking flasks 
(12 h; 30°C; 250 rpm). 
Main-cultivation: 9.5 L SynY media (1 % glucose) was inoculated with 500 mL pre-
culture. For the cultivation a 10 L fermenter was used (30°C; 400 rpm; 1 vvm; 48 h, 
pH 5).For the pH conditioning during the fermentation 30% phosphoric acid and 15% 
ammonia was used. 
 
2.2.14 Tangential flow filtration 
 
For the primary separation a tangential flow filtration setup was selected employing 
the SartoJet-slice system (Sartorius Stedim Biotech GmbH Göttingen). The process 
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included two steps, the cell-separation (micro-filtration) and the concentration / buffer 
exchange (ultra-filtration). For the microfiltration a trans-membrane pressure of 1.5 
was applied using a Hydrosart 0.45 µm membrane (Sartorius Stedim Biotech GmbH 
Göttingen). The filtration took place until the 10 L cell broth was reduced to 0.5 L, the 
cleared supernatant was collected in the permeate. A diafiltration setup was 
employed for the ultra-filtration using a Hydrosart 10 kDa membrane (Sartorius 
Stedim Biotech GmbH Göttingen). The cell supernatant was concentrated to 0.5 – 1 
L and seven diafiltration volumes were applied for buffer exchange. A trans-
membrane pressure of 1.5 was applied also for the ultra-filtration 
 
2.2.15 Anion-exchange chromatography (AEC) 
 
For the purification of GOx an AEC step was performed at pH 6. The applied 
conditions are described in the following. 
 
Table 2-11: Equipment for AEC 
Equipment  
FPLC system ÄKTApilot (GE Healthcare) 
Column FineLine Pilot 35 (GE Healthcare) 
Resin Fractogel TSK DEAE-650 (s) 
Bed volume 220 mL 
 
Table 2-12: Chromatography sequence of AEC 
Step Step length 
[mL] 
Flow rate 
[cm/h] 
Buffer 
Equilibration 660 62.5 sodium phosphate (50 mM, pH 
6) 
Load 500- 1000 62.5 --- 
Wash-1 440 62.5 99% sodium phosphate (50 
mM, pH 6) / 1% sodium 
chloride (1M) 
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Wash-2 440  95% sodium phosphate (50 
mM, pH 6) / 5% sodium 
chloride (1M) 
Elution (10 mL 
fractions were 
collected) 
220 62.5 92.5% sodium phosphate (50 
mM, pH 6) / 7.5% sodium 
chloride (1M) 
Regeneration 440 62.5 sodium chloride (1M) 
Sanitization 660 62.5 Sodium hydroxide (0.5 M) 
Equilibration-2 Until stable pH 
at column exit 
62.5 Water 
Storage 440 62.5 Ethanol (20%) 
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3. Reengineered Glucose oxidase for oxygen independent 
glucose sensing 
 
3.1 Purpose 
 
Oxygen sensitivity, substrate specificity and good electrochemical communication 
(via mediators) are three enzymatic properties which are crucial for accurate 
enzymatic glucose sensing. GOx exhibits excellent β-D-glucose specificities, but 
lacks a specific and efficient electron transfer by artificial mediators due to its high 
oxygen dependency. In order to develop a GOx which meets the requirements for 
accurate β-D-glucose sensing in biological samples, a directed evolution campaign 
was implemented employing a diabetes relevant quinone diimine/ phenylendiamine 
mediator system [3, 68, 69]. The focus of the study was thereby the engineering of 
GOx towards oxygen independency and the adoption of GOx to the quinone diimine/ 
phenylendiamine mediator system by maintaining the high β-D-glucose specificity 
and thermal stability. 
The background of the study and the overall objectives are described in detail in 
chapter 1 and 1.2. 
 
3.2. Strategy 
 
For the identification of relevant residues a specific directed evolution platform 
needed to be established, beforehand of the mutant-library screening. Identified 
residues were investigated individual and cooperatively. The directed evolution 
campaign included the following activities: 
 
 Establishment of a suitable screening system comprising two assays, one for 
oxygen- and one for mediator activity 
 Diversity generation by different random mutagenesis methods 
 Screening the gene diversity for oxygen independency and mediator activity 
 Investigation of identified residues individually and cooperatively by site 
saturation mutagenesis 
 Characterization of selected variants with respect to the desired properties 
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 Computational investigations to construct a GOx model for oxygen 
independency and improved mediator activity 
 
3.3 Results 
 
3.3.1 Establishment of a screening platform 
 
3.3.1.1 The activity assays  
 
Two activity assays had to be established to screen for reduced oxygen dependency 
and for improved mediator activity. The ABTS detection system was employed to 
detect the electron acceptance by oxygen and to screen for variants with reduced 
oxygen dependency. The performance of ABTS assay with respect to directed GOx 
evolution is described elsewhere [39]. Figure 3-1 shows the principle of the activity 
determination employing the ABTS assay. 
 
 
Figure 3-1: Principal of GOx-activity determination by oxidation of ABTS. The in the GOx oxidative 
half reaction produced H2O2 and the added HRP are used to oxidize the chromogenic substrate ABTS. 
The color change of ABTS is monitored by absorption at 414 nm and is proportional to the reduction of 
O2. 
 
A quinone diimine mediator detection system (QDM-1 assay) was established to 
detect variants with increased mediator activity. The system is based on storage 
stable p-nitrosoaniline (N,N-bis(2-hydroxyethyl)-4-nitosoaniline) [3, 68, 69]. Figure 3-2 
shows the principle of the QDM-1 assay. 
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Figure 3-2: QDM-1 detection system. The p-nitrosoaniline gets reduced to hydroxylamine. The 
mediator quinone diimine occurs after spontaneous water elimination and is further reduced by GOx to 
phenylendiamine. Phenylendiamine is reoxidzed (two electron process) with PMOox which is reduced 
to the blue PMOred (recorded at 700 nm). PMO: phosphomolybdic acid [3, 67-69, 106, 107]. 
 
The mediator reaction starts from the p-nitrosoaniline which is converted to the 
corresponding quinone diimine, the actual electron mediator. The quinone diimine is 
further reduced to phenylendiamine, which is deoxidized to the quinone diimine (two 
electron process) [3, 68, 69]. Phosphomolybdic acid (PMO) serves as final electron 
acceptor and indicates the GOx mediator activity [106, 107]. The sceening system is 
based on the activity determination of GOx which is expressed in Saccharomyces 
cerevisiae ngd 29 (Sc ngd29) and secreted to the cell supernatant. The standard 
deviation of the QDM-1 assay in cell supernatants was detected to be 10.2% with a 
linear detection range from 1 to 25 U/L. Screening systems with standard deviations 
below 20 % have often successfully been employed in directed enzyme evolution 
experiments [93, 108, 109]. 
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3.3.1.2 Comparison of two different Saccharomyces cerevisiae expression 
strains 
 
The S. cerevisiae strains Sc. INV (INVITROGEN) and Sc. ngd29 (ROCHE) have 
been tested for the recombinant expression of GOx from Aspergillus niger [42]. Both 
are able to secrete recombinant GOx into the culture medium by employing an N-
terminal MFα-signal peptide [42, 43]. 
The S. cerevisiae strains Sc. INV (INVITROGEN) hyper-glycosylates recombinant 
proteins with an N-glycosylation structure of the type MannGlcNac2. However, a 
uniform glycosylation pattern may play an important role in the industrial production 
of analytical enzymes where a stable product homogeneity has to be ensured. 
Therefore we investigated a hypo-gylcosylation strain Sc. 7087 which provides GOx-
molecules with a uniform asparagine-linked Man8GlcNac2 glycosylation pattern [42].  
To compare the two expression systems in regard to an assay establishment on 
medium high-throughput level, the GOx expressing strains were cultivated in a 96-
well format. The GOx-activity of the resulted supernatants was analyzed using the 
QDM-1 detection system (see 3.3.1.1). Figure 3-3 shows the activity profiles of the 
two different strains always compared to the respective mock-strain. 
 
 
Figure 3-3: determination of GOx-activity in supernatants of two different S. cerevisiae expression 
strains. The cultivation was carried out in microtiter plates. For the activity determination the QDM-1 
detection system was performed in in a 96-well format and absorption at 700 nm was observed for 115 
min. The activities of the two different expression strains were compared to the respective mock-
strains. 
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Figure 3-3 Shows that the initial reaction rate in the supernatant of the GOx 
expression strain Sc ngd29/pYES2-GOx is characterized by a linear slope and it is 
clearly distinguishable from that of the negative control strain (background). However, 
the GOx-activity in the supernatant of the expression strain Sc INV is not detectable 
using the QDM-1 detection system, since it cannot be distinguished between the 
expression strain and the negative control strain. Therefore, the Sc ngd29/pYES2-
GOx strain is more suitable for the expression of GOx in the desired directed 
evolution experiments. The higher GOx-activity in the supernatant of the hypo-
glycosylation strain can be caused either by a higher expression and secretion rate or 
higher enzymatic activity due to the altered glycosylation pattern. The cause of the 
difference between both S. cerevisiae strains will not be investigated within the 
present thesis and further experiments are focusing on the implementation of the Sc 
ngd29 based GOx-screening system. 
 
3.3.1.3 Implementation of an auto-induction media 
 
In 2005 Zhu et al. published a two-step strategy to cultivate S. cerevisiae in 
microtiter-plates [110]. Step one is a cell growth step in which the cells utilize glucose 
as a carbon source. In step two the galactose inducible promoter gets induced by 
galactose in the media. The method provides that the glucose containing media is 
exchanged by a galactose containing media after a certain growth phase, which 
ensures a growth-uncoupled expression of the recombinant protein. Apart from a 
high working effort, the media exchange leads to a long lag-phase, which may result 
in less formation of the recombinant protein. 
Since the galactose inducible promoter is repressed by glucose and glucose is the 
preferred carbon source for S. cerevisiae, a growth-uncoupled recombinant protein 
expression should also be possible using an auto-induction approach. Figure 3-4 
shows the initial reaction rates of Glucose oxidase in cell-supernatants under 
different cultivation conditions applying the QDM-1 detection system in microtier-
plates (see chapter 3.1.3.1). To establish a suitable auto-induction media the 
cultivation was performed for 48- and 72 h using different concentrations of glucose 
for cell growth and galactose as well as maltose for induction (based on SC-U 
media). Three different expression strains were selected for the experimental setup; 
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the Sc ngd29 negative control strain, the Sc ngd29 strain expressing GOx wild type 
and the Sc ngd29 strain expressing a variant of GOx (GOx T30VI94V) [43]. 
 
 
Figure 3-4: GOx-activity in cell-supernatants after 48 h (a) and 72 h (b) cultivation using different 
Glucose concentrations for cell-growth and different galactose/maltose concentrations for induction. 
 
Figure 3-4 shows clearly higher activities in the media with 0.5 % glucose compared 
to 1 % glucose for all approaches. Furthermore, there is a preference for galctose 
over maltose as an inductor. Cultivations for 72 h clearly deliver higher activities than 
those over 48 h. The best result was obtained using 0.5 % glucose in combination 
with 2 % galactose and a cultivation time of 72 h. The detailed cultivation conditions 
are described in the material and methods section. 
 
3.3.2 Gene mutagenesis and screening of mutant libraries 
 
Figure 3-5 shows a scheme of directed GOx evolution for reduced oxygen 
dependency and improved mediator activity. The campaign started from the parent 
variant GOx-T30VI94V, a variant that exhibits a increased thermal stability (from 
58°C to 62°), a increased pH stability (at alkaline pH, 8-11) as well as a increased 
catalytic efficiency (kcat: 69.5/s to 137.7/s) [40]. After diversity generation on gene 
level the host stain Sc ngd29 was transformed and isolated cell clones were 
cultivated in 96-well plates. Cell supernatants were investigated employing the ABTS- 
and the QDM-1 detection system in parallel in order to indentify variants with reduced 
oxygen dependency and improved mediator activity. In the pre-screening each clone 
was investigated once and promising candidates were selected. The candidates were 
analyzed 12-times in a re-screening approach for statistical assessments. 
Subsequently, DNA-sequence analysis of selected variants took place. Mutated  
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genes from improved variants were subjected to a further round of directed evolution 
(iterative cycles). 
 
 
 
Figure 3-5: Directed evolution platform for Glucose oxidase. The experiment includes the steps; 
diversity generation on gene level, transformation of Saccharomyces cerevisiae ngd 29, cultivating 
and screening for desired properties (pre-screening/re-screening), gene isolation and sequence 
analysis. Genes of selected variants serve as parents for the next evolution round (iterative cycles). 
 
 
Two iterative cycles of directed evolution were performed to identify GOx residues or 
regions which either modulated oxygen activity or mediator activity (Fig. 3-6). In the 
first cycle the mutant library was generated by the SeSaM technology [85] based on 
the parent GOx-T30V I94V. The two best variants from the SeSaM library (A173T, 
A332S) were used as parents for the second cycle in which an error-prone-PCR 
mutant library (epPCR; 0.1 mM MnCl2) was screened.  
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Figure 3-6: Overview of the directed GOx evolution campaign. The campaign was performed to 
decrease the oxygen dependency and to increase the mediator activity. Two iterative cycles of random 
mutagenesis were performed yielding four beneficial positions (A173, A332, F414, and V560). All four 
positions were mutagenized either individually (QuikChange; -NNK) or simultaneously (OmniChange; 
reduced amino acid subsets) [67]. 
 
 
 
The random mutagenesis yielded four beneficial substitutions (A173T, A332S, 
F414L, V560A). V1 (A173T) and V2 (A332S) showed increased oxygen and mediator 
activity in the ABTS and in the QDM-1 assay (V01: 170% QDM-1 assay, 165% ABTS 
assay; V2: 175% QDM assay, 135% ABTS assay - residual activity of reference 
GOx-T30V I94V). In contrast, V3 (A173T F414L) and V5 (A332S V560A) showed 
significantly decreased oxygen activity (< 30% than GOx reference) in combination 
with a slightly increased mediator activity (V3: 200%; V5 160% - residual activity of 
GOx reference).  
All four identified positions were further investigated by individual site saturation 
mutagenesis to elucidate their functions (with respect to oxygen independency and 
mediator activity) and to assess the most beneficial substitution for each residue. 
Table 3-1 summarizes the sequencing results of the individual site saturation 
approach and the properties of each residue. 
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Table 3-1: Sequence analysis of individual saturated positions in GOx variants and influence of 
identified positions (A173, A332, F414, V560) on mediator and oxygen activity. Clones from the 
mutant libraries were selected based on increased mediator activity and / or decreased oxygen 
activity. Substitutions and the number of occurrence in 11 to 18 sequenced clones are given [67]. 
 
 
Residue 173 and 332 contribute to the increased oxygen and mediator activity. 
Substitutions of residue 414 resulted mostly in improved mediator activity but also in 
reduced oxygen activity (F414M). Residue 560 is crucial for the reduced oxygen 
dependency of GOx; substitutions to L, P, T, W or Q led to a substantial decreased 
oxygen activity while maintaining the mediator activity (Tab. 3-1). 
Results of the individual site saturation experiments prove that the identified residues 
allow to modulate individual or jointly (V3, V5) the oxygen sensitivity and mediator 
activity. An overview of the location of all identified residues in the GOx-WT is given 
in Fig. 3-13. 
 
 
For the assessment of cooperative effects an OmniChange multi-site site saturation 
experiment [102] was performed including all four residues (A273, A332, F414, 
V560). Since a screening of the full diversity with 20 aa / 32 codons (NNK) at 4 
positions would generate 1.05 mio. gene variants, a reduced subsets of amino acids 
were selected for each position, according to the most frequent amino acids in a 
multiple sequence alignment of Gox and oxygen independent glucose 
dehydrogenases (Tab. 3-2). 
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Table 3-2: Selected amino acid set for simultaneous site saturation of identified positions using the 
OmniChange method [67]. 
Residue Subset of amino acids Degenerated 
codons 
173 AITV RYT 
332 SN ART 
414 CDFGHILNRSVY NDT 
560 AILMPTV VYK 
 
The reduced OmniChange library consisted of 1152 codon variants and 2112 clones 
were screened (theoretically 94% coverage) [111]. The OmniChange library was 
screened with respect to reduced oxygen independency and improved mediator 
activity yielding five variants (V6-8; V10-11) exhibiting significantly improved 
properties (less oxygen sensitivity; higher mediator activity) compared to those of the 
individual site saturation experiment. Tab. 3-3 summarizes the sequencing results 
and the residual activities of the five selected OmniChange variants. The residual 
activities are based on the comparison of the specific activities (oxygen and mediator 
activity at 34 mM β-D-glucose) of the GOx reference (GOx T30V I94V) and the 
respective variant.  
 
Table 3-3: Results of the OmniChange multi-site saturation library of the GOx reference variant (GOx-
T30V I94V). GOx variants were selected according to mediator and / or lower oxygen activity. 
Sequencing results are reported for the positions 173, 332, 414, and 560 with improvements in 
mediator and/or oxygen sensitivity. 34 mM ß-D-glucose was used in all activity determinations. 
Calculations are given in % as ratios of specific activities (U/mg) compared to the GOx reference 
variant (RV; T30V I94V). n.d.: not detected [67]. 
  Substitutions  Residual activity (%) 
Variant  A 
173 
A 
332 
F 
414 
V 
560 
 Mediator 
activity 
Oxygen 
activity 
V6  I S L V  160 30 
V7  V S I T  440 n.d. 
V8  V N F P  100 n.d. 
V10  V N V L  243 n.d. 
V11  A S F P  120 n.d. 
 
All values in Tab. 3-3 were calculated using GOx containing cell supernatants without 
any protein purification steps; recorded values have therefore to be considered as 
apparent values which were used for the selection of the most beneficial variants V7 
and V10. 
 
Reengineered Glucose oxidase for oxygen independent glucose sensing 40 
V7 and V10 exhibit increased mediator activity (reference variant: 3.2 U/mg; V7: 14.1 
U/mg; V10: 7.8 U/mg) by simultaneously reduced oxygen activity (reference variant: 
296 U/mg; not detected for V7 and V10 under selected conditions).  
To select a final variant, substrate specificity and thermal stability was determined for 
all variants (V6-8; V10-11; data not shown) in order to ensure that the high β-D-
glucose specificity and thermal stability of GOx was maintained during directed 
evolution. V7 showed for the latter two properties a comparable performance to the 
GOx reference (specificity: Tab. 3-5; thermal stability: Fig. 3-7). In essence, V7 
exhibited after pre-characterization (in yeast cell supernatants) all required properties 
and was selected for detailed characterization. 
 
3.3.3 Characterization of V7, reference variant (RV) and WT 
 
V7, RV (GOx-T30V I94V) and WT were produced in Sc ng29 in 10L scale and 
subsequently purified according to the material and method section. The 
establishment of the GOx production process is described in chapter 5. Purified GOx 
and variants (content > 90%) were subjected to kinetic investigations employing the 
QDM-1 assay and the ABTS assay. Michaelis-menten kinetics were recorded and the 
enzymatic parameters (Vmax; KM) were obtained by non-linear regression. Table 3-4 
summarizes the kinetic parameters and the residual activities of V7, RV and WT. 
 
Table 3-4: Kinetic parameters and residual activities of WT, RV, and V7. Kinetic parameters (vmax; KM) 
were obtained by non-linear regression based on the Michaelis-Menten model using GraphPad Prism 
software package. 
  Mediator assay  ABTS assay 
Vmax 
[U/mg] 
Residual 
activity 
KM 
[mM] 
 Vmax 
[U/mg] 
Residual 
activity 
KM 
[mM] 
WT 7.4±0.1 100 % 13.2±1.0  172.3±4.2 100 % 14.2±1.3 
RV (T30V-I94V) 13.7±0.2 184 % 11.9±0.9  221.6±6.0 128 % 8.7±1.0 
V7 47.5±1.0 638 % 28.2±1.9  30.1±0.2 17 % 1.3±0.1 
 
V7 has 638 % residual activity in the QDM assay (WT: 7.4 U/mg; V7: 47.5 U/mg) and 
17 % residual activity in the ABTS assay (WT: 172.3 U/mg; V7: 30.12 U/mg), 
resulting in a 37.5 times reduced oxygen dependency (Residual activity QDM assay / 
residual activity ABTS assay - OI-ratio) when compared to WT and RV (OI-ratio WT: 
1; OI-ratio T30V I94V: 1.4). 
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Oxygen activity was determined indirectly by applying the coupled ABTS-assay. For 
final characterization and in order to validate the ABTS results an oxygen probe 
(Oxygen Meter - Precision Sensing GmbH Regensburg) was used to directly 
measure the oxygen consumption [%-/min]. The direct oxygen consumption 
measurements yielded comparable results, for instance in case of V7 (17 % ABTS 
assay; 22 % oxygen probe). In detail, a rate of 3.9 %/min was observed for V7, 17.4 
%/min for WT and 24.2 %/min for RV. 
V7 is attractive for amperometric ß-D-glucose determination if the specificity for ß-D- 
glucose is kept during directed GOx evolution in order to avoid cross-reactivity with 
clinical relevant sugars (β-D-maltose, maltotriose, β-D-galactose, and D-xylose). 
Table 3-5 summarizes residual activities of GOx, WT, RV, and V7 for β-D-maltose, 
maltotriose, β-D-galactose, and D-xylose. WT, RV, and V7 activity for ß-D-glucose 
were set to 100 % as reference value and the QDM assay was employed in 
specificity studies. 
 
Table 3-5: Residual activities of WT, RV, and V07 on ß-D-maltose, maltotriose, ß-D-galactose and D-
xylose. Activity was determined using the QDM-assay and 182 mM of each sugar was employed in 
activity measurements. WT, RV, and V7 activity for ß-D-glucose were set to 100% as reference value. 
n.d.: not detected.  
  Residual activity [%] 
  WT RV V7 
ß-D-Glucose  100.0±1.10 100.0±2.10 100.0±0.30 
β-D Maltose  n.d. n.d. n.d. 
Maltotriose  0.2±0.01 0.8±0.03 0.3±0.01 
β-D-Galactose  1.1±0.08 1.0±0.02 0.4±0.02 
D-Xylose  0.4±0.04 0.3±0.02 1.7±0.01 
 
Overall, the activities for β-D-maltose, maltotriose, β-D-galactose and D-xylose are 
less than 2 % of the glucose activity in WT, RV and V7 and differ less than 1.3 % 
among all investigated sugars. Therefore the specificities of WT, RV and V7 can be 
regarded as nearly unaltered for diabetes relevant sugars. V7 has a neglectable 
increased activity for D-xylose (from 0.38 % to 1.66 % residual activity) and 
interestingly the β-D-galactose activity is slightly reduced from 1.08 % to 0.42 %. 
Additionally none of the three GOx enzymes has a detectable activity on maltose (for 
experimental setup see material and methods section).  
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Furthermore the thermal resistance of GOX-WT and variants was investigated to 
ensure no stability loss during GOx evolution (Fig. 3-7). 
 
 
Figure 3-7: Thermal resistance of WT, RV, and V7 determined after thermal incubation (15 min; 25-
65°C) and subsequent cooling on ice. Activities were determined with the QDM-1 detection system 
employing 182 mM ß-D-Glucose. Figure was prepared using the GraphPad Prism software package 
(La Jolla California USA)  
 
Thermal resistance of GOx WT, RV, and V7 was determined after 15 min incubation 
at varied temperatures (25-65°C in 5°C steps) as shown in Figure 3-7. The activity 
after incubation at 25°C was set to 100 %. GOx WT and variants exhibit a high 
thermal resistance up to 50°C, no significant difference between WT, RV and V7 
could be observed. 
 
3.3.4 Further optimization of GOx  
 
Two further residues of GOx from A. niger were investigated with respect to improved 
GOx activity. A137 was identified within the second round of directed GOx-evolution 
(epPCR – see chapter 3.1.4) and S53 within an additional third cycle (Fig.-3.8). 
 
 
Figure 3-8: Overview of the directed GOx evolution campaign. The campaign was performed to 
decrease the oxygen dependency and to increase the mediator activity. Two iterative cycles of random 
mutagenesis (SeSaM; epPCR) were performed yielding four beneficial positions (A173, A332, F414, 
and V560) for oxygen dependency and mediator activity, which were further investigated (see 
chapter 3.1.4). The additional residues A137 from cycle two and S53F from an additional 
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SeSaM library (SeSaM-2, iterative cycle 3) were considered as independent overall-activity 
residues and were further investigated by site saturation mutagenesis (QuikChange; -NNK). 
 
Fig. 3-8 shows a modified directed evolution scheme for GOx (see also chapter 
3.1.4). The additional Variant A173T A137S (in the following named as V4) was 
identified in the second cycle during the epPCR screening. V4 showed an 
approximately 1.7-fold improvement in the GOx activity, for the ABTS-assay as well 
as for the QDM-1 detection system. The gens of all so far identified variants (cycle 
1+2) were used as parents for the construction of the mutant library of the third cycle 
of directed GOx evolution. Only the variant A332S S53F (in the following named as 
V12) was identified as a 3rd generation variant with improved properties. This variant 
showed similar properties as V4, with slightly less activity in the oxygen activity 
compared to the mediator activity. None of the two variants showed a significant 
alternation in the oxygen to mediator activity ratio. Both new identified residues (A137 
and S53) were considered as overall activity improving residues and were not 
included in investigations towards an oxygen independent GOx (see chapter 3.14 / 
3.15). Nevertheless both residues were subjected for individual site saturation 
mutagenesis in order to investigate the whole diversity for each position. Site 
saturation studies revealed leucine as the best substitution for residue 137 with an 
activity improvement of around 5-fold in compare to GOx- T30VI94V. The substitution 
from serine to phenylalanine was the best for residue 53 with an activity improvement 
of approximately 2-fold compared to GOx T30VI94V. 
Since the substitutions of the residues 52 and 137 were considered as independent 
activity positions, an incorporation of the substitutions into V7 were investigated with 
the objective to raise the activity of V7 without altering the oxygen independency. 
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Figure 3-9: Incorporation of S53F and A137L into V7. The substitutions were incorporated in the GOx 
gen employing the QuikChange method. After transformation of Sc. ngd29 the respective cell clones 
were cultivated in 96-well plates and clarified cell supernatants were subjected to activity 
determinations employing the QDM-1 detection system (mediator activity) and the ABTS-assay 
(oxygen activity). 
 
Figure 3-9 shows the relative activities of the WT to respective variants including the 
combinations of V7 with the substitutions S53F and A137L. The combination of V7 
with S53F as well as with A137L leads to improved activities in the QDM-1 detection 
system without altering the oxygen activity of V7 under the selected conditions. Also 
the combination of V7 with both substitutions improves the activity of V7, whereby no 
clear distinction is possible between V7 + S53F + A137L and V7 + S53F. It needs to 
be stated that these investigations were implemented with not purified enzymes in 
yeast cell supernatants and needs to be considered as preliminary results. For a 
clear assessment of the combinations a characterization in more detail would be 
necessary. 
 
3.3.5 Computational assessment of V7 and residue A137 
 
Computational investigations were implemented by the sub-group for computational 
biology of the chair for biotechnology (Dr. Marco Bocola, RWTH Aachen University). 
The results of the entire computational study are summarized and published within 
the master thesis of Alexandra Bălăceanu [112].  
The scope of this chapter is the theoretical investigation of the oxygen activity for WT, 
V7, V8 and an external reference (GOx T110A [41]). 
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3.3.5.1 Selected variants and model preparation 
 
The X-ray crystal structure of Glucose oxidase from Aspergillus niger was obtained 
from the Protein Data Bank entry 1CF3 [53] and prepared for molecular modeling 
activities [112]. In order to assess the oxidative half reaction a dimeric GOx model 
with bound substrate and product was constructed and validated with respect to the 
reduction state of the cofactor (semi-reduced FADH- form) and the protonation state 
of the active site histidines (His 516 and His 559 fully protonated). The model 
construction and validation is described in detail in Bălăceanu 2013 [112]. 
The three additional model structures V7, V8 and T110A were created. The 
experimental characterization of V7 was shown in chapter 3.1.5. V8 was introduced 
in chapter 3.1.4 and showed excellent properties with respect to oxygen 
independency, but was not further analyzed due to low mediator activity and residual 
activity on xylose. T110A was published by Horaguchi et al. and exhibits a 6-fold 
higher dehydrogenase/osidase ratio [41], this variant was selected as a comparison 
to V7 and V8. Table 3-6 summarizes the substitutions of the respective variants. 
 
Table 3-6: GOx variants and respective amino acid substitutions. 
Variant T110 A173 A332 F414 V560 
V7 - Val Ser Ile Thr 
V8 - Val Asn - Pro 
T110A Ala - - - - 
 
Substitutions in the GOx structure were introduced using FoldX considering stability 
changes upon the substitution and by allowing all residues within a 6 Å radius around 
the substitution to be moved, obtained structures were energy minimized in water 
[112].  
 
3.3.5.2 Oxygen placement and MD-simulations 
 
Solvent accessible molecular surfaces were studied and it has been found that WT 
exhibits an oxygen stabilizing pocket close to the active site [112] (Fig. 3-10). 
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Figure 3-10: Oxygen stabilizing pocket in GOx WT. The pocked has been discovered by the 
comparison of solvent accessible surfaces. Oxygen was placed in this pocked and the respective 
complex was energy minimized [112].  
 
For the WT the oxygen was placed in the oxygen stabilizing binding pocket. For V7, 
V8 and T110A this binding pocket could not be observed and the oxygen molecule 
was initially placed as close to the cofactor as possible. Obtained protein-oxygen 
complexes were subsequent energy minimized [112].  
Two different rotamers were found for V7 during model preparation and each rotamer 
showed a different behavior towards oxygen. In one rotamer of V7 a new pocket is 
formed in which oxygen can be stabilized (Rotamer 2). This pocket cannot be 
observed in the second rotamer (Rotamer 1) (data provided from the subgroup of 
computational biology, Marco Bocola). 
The received structures were used as a starting point for molecular dynamic 
simulations over 5 ns with the active site H516 in a protonated state. The trajectory 
analysis was implemented to assess the GOx-oxygen models whereby the distance 
from oxygen to the N5 atom of the FDH- and the distance F215 were followed (Tab 3-
7). F215 is a residue of the observed oxygen pocket in GOx WT. 
 
Table 3-7: Recorded average distances of the oxygen radical to the N5 atom and to F215 during 
molecular dynamic simulations. Data provided by the subgroup for computational biology. 
Oxygen WT V7 – Rot 1 V7 – Rot 2 V8 T110A 
Dist FAD [Å] 9.3 12.1 7.8 20.4 18.4 
Dist F215 [Å] 4.0 14.1 5.5 24.2 19.3 
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Figure 3-11 shows the time evolution of the distance of the oxygen radical to the N5 
atom of the FDH-.  
 
Figure 3-11: Time evolution of the oxygen radical to the N5 atom of the FAD over 5 nS. Data provided 
by the subgroup for computational biology, Marco Bocola. 
  
Figure 3-10 shows that the distance of the oxygen to the cofactor is increasing 
drastically for V8 and T110A after 3.5 ns and that the oxygen is leaving the active 
site. The oxygen is also leaving the active site for V7 rotamer 1, but for rotamer 2 the 
oxygen remains in a close vicinity to the FAD similar to what is observed for the WT. 
The reduced capability to stabilize oxygen might explain the experimental data 
received for V7 and V8. 
 
3.3.5.3 The surface residues A137 and A173 
 
Additional to the two active site residues F414 and V560 the three surface residues 
A137, A173 and A332S were identified as “hot spots”. Substitutions in all three 
surface residues resulted in an increase in the activity of GOx for oxygen and for the 
mediator activity (see chapter 3.1.4 and 3.1.6), whereby only A332 is located close to 
substrate entrance channel. Analysis of the internal cavities of GOx in the published 
X-ray structure [53] proposed an additional channel from active site towards the 
residues A137 and A173 on the surface as an alternative entry / exit route for 
oxygen, hydrogen peroxide and water (Fig. 3-12) [112]. 
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Figure 3-12: Solvent accessible surface representation of GOx. The representation proposes a 
channel from the active site towards the identified “hot spots” A137 and A173. A137 and A173 were 
identified during directed evolution of GOx (see chapter 3.1.4 / 3.1.5). Figure modified after A. 
Bălăceanu 2013 [112]. 
 
3.4 Discussion 
 
In enzymatic biosensors, the performance of the enzyme, regarding the biochemical 
reaction as well as the enzyme stability, are directly linked to the performance of the 
sensor. Oxygen independency and substrate specificity are two major aspects for the 
improvement of enzymatic glucose sensors in diabetes care with respect to accuracy 
and robustness. Furthermore, in test stripe analytics the employed electron mediator 
needs to meet certain requirements such as storage stability, high electron transfer 
rates and low unspecific interactions. The goal of the present work was to design an 
“optimal” GOx for diabetes analytics regarding oxygen independency electron 
transfer, but also to get a deeper understanding of the enzymatic mechanism. To the 
best of my knowledge there is to date only one report in which GOx was improved 
towards reduced oxygen activity employing phenazine methosulfate as electron 
mediator [41]. Phenazine methosulfate is not employed in diabetes care applications. 
In this study a quinone diimine/phenylendiamine (QDM) mediator system was used 
which is successfully employed in diabetes care systems [3]. 
The present dissertation comprises the establishment of a suitable screening 
platform to select GOx variants with the desired properties, the directed evolution of 
the GOx from A. niger, the presentation of an enzyme model and the development of 
a pilot scale GOx production process. The results of each topic will be discussed 
individually. 
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3.4.1 Establishment of a screening platform and comparison of two suitable 
host organisms. 
 
The ultimate goal of the present work was to reduce the oxygen activity of the A. 
niger GOx by simultaneous improvement of the mediator activity. In order to select 
such variant libraries needed to be screened for both properties, the oxygen activity 
and the mediator activity. To assess the oxygen activity the well kwon ABTS-assay 
was employed, the assay served as a control method to rather monitor the oxygen 
activity than to assess the enzyme performance. The ABTS-assay was already 
successfully employed in directed evolution campaigns and will not be discussed 
within this chapter [39].  
To select variants which are well suited for the desired application it is important to 
design a screening assay which works under conditions that are as similar as 
possible to those of the desired application. Therefore, a quinone 
diimine/phenylendiamine (QDM) mediator system was selected to screen for variants 
that exhibit excellent electron transfer rates independent of the presence of oxygen. 
Quinone diimine/phenylendiamine systems are attributed by low unspecific 
interactions and a high storage stability in the applied p-nitrosoaniline form [3, 68, 
69]. The assay conditions were adopted from a protocol provided by the cooperation 
partner (Roche) to a 220 µL scale in 96-well plates. The initial concentration of the 
mediator pre-compound N,N-bis(2-hydroxyethyl)-4-nitrosoaniline was set to 8.7 mM 
in the assay, a concentration which is close to the concentration that is needed for 
the test stripe application. 
The comparison of the two different S. cerevisiae strains Sc. INV and Sc. ngd29 
showed that only the mediator activity of GOx expressed in Sc. ng29 can be detected 
employing the QDM-1 detection system. A clear and linear reaction rate was 
observed after an initial lag-phase and the reaction rate was significantly different to 
the assay background detected with the negative control strain (Fig. 3-3). The initial 
lag phase of the QDM-1 assay might be attributed to the conversion of the p-
nitrosoaniline to the active mediator component (chinondiimine). This initial activation 
of the p-nitrosoaniline by GOx is always necessary at the beginning of the reaction 
since the corresponding chinondiimine is not storage stable – no electrons can be 
transferred from the redox centre of the GOx during the mediator activation. It was 
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not possible to distinguish between the negative control strain and GOx expressing 
strain of the commercial available Sc. INV. This can be traced back to a higher assay 
background produced by the Sc. INV itself and also to lower detectable activities 
compared to the Sc. ngd29 (Fig 3-3). The lower GOx activity in the supernatants of 
the Sc. INV can be attributed to lower expressions rates and also to a sterically 
blocked substrate availability due to the a high occupation of the GOx surface with 
carbohydrates since the carbohydrate content can be 10 -16 % for GOx’s expressed 
in organisms providing a N-glycosylation structure of [Mann][GlcNAC2]. 
In order to establish a reliable and easy screening system an auto-induction 
cultivation strategy was developed by testing different cultivation times in combination 
with either different glucose/galactose - or different glucose/maltose concentrations 
(Fig. 3-4). The figure shows that 72 h is the preferable cultivation time for all tested 
combinations. This result comes from the balance between the initial cell growth on 
glucose and subsequent expression of the recombinant GOx. The expression of the 
GOx is in the selected expression system controlled by the Gal1-promoter for which it 
is assumed that the gene transcription is induced in case of β-D-glucose limitation 
and the presence of D(+)-galactose [113, 114]. The better GOx activity after the 
longer cultivation indicates that either residual glucose was available after 48 h, 
attributing a lower cell density combined with a weak expression, or that a longer 
expression phase leads to the formation of more GOx over the time. The fact that 
also the approaches with less glucose (0.5 % instead of 1 %) lead to a better result 
supports the hypothesis that after 48 h of cultivation the residual concentration of 
glucose in the cultivation media was still too high. It can be concluded from the 
results that the ratio of glucose concentration to cultivation time is a crucial aspect in 
the development of an auto-induction media employing the selected expression 
system. The comparison of galactose and maltose as inducers showed the expected 
results with a clear preference to galactose. The best conditions with respect to the 
GOx activity in the screening assay was 0.5 % glucose in combination with 2 % 
galactose over the cultivation time of 72 h. 
The final QDM-1 screening system was assessed with respect to the standard 
deviation over a whole 96-well screening plate in order to state the accuracy and 
suitability of the assay. The determined standard deviation of the mediator assay of 
10.2 % with a linear detection range from 1 to 25 U/L makes the QDM-1 detection 
system to an excellent assy in 96-well plate format. Screening systems with standard 
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deviations below 20 % have often successfully been employed in directed enzyme 
evolution experiments [93, 108, 109]. 
 
3.4.2 Reduction of the oxygen sensitivity and improvement of mediator 
activity 
 
A measure for the oxygen independency of GOx variants is the ratio mediator to 
oxygen activity termed as OI-ratio (Oxygen-Independent GOx ratio) in the whole 
thesis. 
Two iterative cycles of directed evolution were executed, one with SeSaM (cycle 1) 
and one with epPCR (cycle 2). Two beneficial positions were identified in cycle one 
(A173, A332) and two in cycle two (F414, V560), substitutions in those positions 
affect either oxygen sensitivity, mediator activity or even both. Figure 3-13 shows an 
overview of the location of all four residues in the GOx (1cf3) x-ray structure [53, 67].  
 
 
Figure 3-13: Ribbon representation of GOx from A. niger based on the x-ray structure 1cf3 [53]. F414, 
V560, A173, and A332 are identified “Hot-spots” for high mediator activity and reduced oxygen activity 
after two rounds of directed GOx evolution. H516 and H559 are highlighted as catalytic active residues 
along with FAD in the active site. Ribbon representation was prepared using the Discovery Studio 
software package [55]. Figure after E. Arango et al., 2013 [67]. 
 
A173 is located at the surface of the GOx, 14.8 Å away from the FAD and catalytic 
histidines. A332 is also a surface residue, located close to the substrate entrance 
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channel with a distance of 14.6 Å to the flavin isoalloxazine. F414 it is located 8.2 Å 
above the FAD in the substrate binding pocket and V560 neighbors the active site 
residues H516 and H559 [57]. 
Two focused site saturation approaches (individual site saturation with QuikChange; 
simultaneous site saturation with OmniChange) were implemented to asses each of 
the identified hot spots and in order to create an “ideal” GOx. 
Since two of the identified residues are in close vicinity of the active site (414, 560) 
and two within 14.8 Å of the FAD (173, 332) cooperative effects seemed to be likely. 
Therefore, the simultaneous site saturation mutagenesis with OmniChange was 
performed including all four positions (137, 332, 414, 560). The simultaneous site 
saturation approach delivered V7, a variant which exhibits an approximately 2.5 times 
higher OI-ratio than the best variant obtained from the random mutagenesis libraries 
(data not shown). V7 shows a 6.4-fold increase in specific activity with the quinone 
diimine mediator (WT: 7.4 U/mg; EZ07: 47.5 U/mg) and a 5.7-fold reduced activity 
with oxygen (WT: 172.3 U/mg; EZ07: 30.12 U/mg) resulting in a 37-fold reduced 
oxygen dependency (OI-ratio). The only reported GOx from A. niger which was 
engineered for reduced oxygen sensitivity was the GOx-T110A with a 6-fold reduced 
oxygen dependency [41]. 
The goal of the individual site saturation experiment was to elucidate the specific 
impact of each identified residue on the oxygen sensitivity and the mediator activity. 
Substitutions of the two surface positions A173 and A332 showed to increase the 
mediator- as well as the oxygen activity (up to 3-fold; Tab 3-1). A substitution to the 
aliphatic and non polar alanine was the most favorable for both positions. The 
substitutions to threonine, a polar and hydrophilic residue, showed the similar effect 
for position 332. A173 is located at the surface of the GOx and 14.8 Å away from the 
FAD, a computational analysis of the inner cavity of the GOx suggest the existence of 
a channel from the active site towards this residue (see chapter 3.1.7.3). This 
channel maybe provides an alternative entry / exit route for oxygen and hydrogen 
peroxide as one possible explanation of the influence by residue 173. A332 is located 
at the substrate entrance channel with a distance of 14.6 Å to the flavin isoalloxazine. 
Substitutions from alanine to more polar residues such as serine (V7) or asparagine 
might support an easier entering of channel by the oxygen molecule. The exact 
contributions of the individual substitutions and how the best performing variants 
(A173V and A332V, individual site saturation) improve mediator activity and oxygen 
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activity remains to be studied by in-depth computational and structural analysis. 
Position F414 is responsible for increased mediator activity by substitutions from F to 
M, V, L or I. F414 it is located 8.2 Å above the FAD (Figure 2) in the substrate binding 
pocket and involved in the β-D-glucose binding [57]. After gluconolactone formation 
and dissociation from the active site [57], an oxygen molecule or a mediator acts as 
electron acceptor from the reduced cofactor FADH2. The substitutions from F to 
aliphatic M, V, L or I indicate that a change in flexibility and size of the side chain is 
mainly contributing to an increased mediator activity. The location of the position 414 
suggests the hypothesis that the QDM (quinone diimine mediator) can directly bind in 
the binding pocket to reoxidize FADH2 efficiently. The latter hypothesis is supported 
by molecular docking results (4.3.3) in which the quinone diimine mediator compound 
binds directly in the active site, in close vicinity to residue F414 and the FAD. The 
binding efficiency (mediator affinity) and the associated electron transfer rate is 
thereby very likely depending on the mediator chemistry, the mediator size and the 
amino acid side chains surrounding the binding pocket. The latter renders it likely that 
improved mediator activities are dependent on the identified amino acid substitutions 
and specific for the employed mediator system. The further studies with the QDM are 
discussed in chapter 4. 
The position V560 is most important for “oxygen sensitivity” and substitutions to L, P 
or T drastically reduce oxygen activity. V560 neighbors the active site residues H516 
and H559 which are involved in shuttling of protons from FADH2 to oxygen. 
Replacement of V by T can perturb the catalytic hydrogen-bond network (FAD, H559, 
H516, E412) due to an additional hydroxyl group (V560T). Replacement of V560 by L 
or P might alter the orientation of the neighboring catalytic residue H559. Therefore 
the oxygen activation and binding between FAD and His 559 is perturbed by 
substitutions in position 560. 
A Computational analysis was investigated in order to assess the function of V7 and 
built a model for oxygen independent GOx. Comparison of the molecular surfaces 
revealed that only the WT has an opening to a pocket close to the active site which 
stabilizes oxygen in a reactive conformation close to the cofactor FAD. This pocket 
was not accessible in any of the studied variants (see chapter 3.3.5.2). A first 
conclusion was drawn in which the reduced oxygen activity of the variants V7, V8 
and T110A is traced back to e reduced capability to bind oxygen in a reactive 
position. Furthermore, two different rotamers were found for V7. One of those opens 
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a new pocket which is able to stabilize oxygen, while the other doesn’t. The existence 
of two rotamers might explain the residual oxygen activity of V7. The latter two results 
were proven by molecular dynamic simulations. The time evolution of the distance of 
the oxygen radical to the N5 atom of the FAD showed that in case of V7 rotamer one 
(without oxygen binding pocket) , V8 and T110A the oxygen is not only leaving the 
reactive position within the active site, but the enzyme completely (Fig 3-11). A. 
Bălăceanu [112] showed in a structural comparison of WT and V8 that the 
accessibility of the oxygen stabilizing pocket in the WT can be controlled by changing 
the orientation of the H559 in the active site. The computational analysis clearly 
demonstrated that substitutions of V560 change the capability of GOx to stabilize 
oxygen in the active site what leads, like in case of V7 and V8, to drastically reduced 
oxygen activity without altering the enzyme stability or specificity. 
 
3.4.3 Further improvement of GOx towards increased catalytic activity 
 
Two further residues, A137 and S53, were investigated with respect to GOx activity. 
A137 was identified in the first two rounds of directed evolution in the combination 
A137S + A173T and S53 was identified in the third round of directed evolution as the 
combination S53F+ A332S (see chapter 3.4). Individual site saturation experiments 
of both residues resulted in the two single substitutions A137L and S53F as the best 
variants (A137L: 5-fold activity improvement compared to T30VI94V; S53F: 2-fold 
activity improvement compared to T30VI94V). None of the two substitutions altered 
the oxygen sensitivity of GOx. Furthermore, it was shown that the addition of the two 
substitutions to V7 increase the mediator activity without changing the oxygen activity 
of V7 what leads to a further increase of the OI-ratio of V7 (a detailed 
characterization was not executed). 
Position 137 is a surface position and is located at the exit of a channel which is 
formed from the active site (Figure 3-11). As it was already described for A173 (see 
chapter 4.2) this channel might offer an alternative entry / exit route for oxygen and 
hydrogen peroxide. The mechanism of influence of substitutions from alanine to 
leucine still needs to be investigated in further studies. S53 is also a surface position, 
but is located on the dimer interface and might be involved in the stabilization of the 
dimer. 
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3.4.4. Oxygen independent GOx’s in industry – The Impact on diabetes 
analytics 
 
Common glucose meters in diabetes analytics are based on electrochemical 
biosensors employing GDH’s or GOx’s for molecular glucose recognition (see 
chapter 1 and 1.4). Certain requirements need to be fulfilled in order to ensure a 
specific, accurate and stable glucose monitoring: 
 
 High glucose specificity 
 Oxygen independency 
 Interference free electron shuttling 
 Enzyme and mediator stability. 
 
High glucose specificity can be ensured by the use of GOx’s whereby for oxygen 
independent systems GDH’s are used (see also chapter 1) [3, 9]. However, both 
enzymes exhibit good stability properties. Quinone diimine electron mediator (QDM) 
systems are often employed in diabetes analytics and ensure a specific electron 
shuttling between the enzyme and a counter electrode. QDM systems attribute low 
unspecific interactions with blood components and an excellent storage stability in 
form of N-substituted p-nitrosoanilins (see chapter 1.4.1).  
The main challenge in glucose monitoring is the development of sensors which 
combine a high β-D-glucose specificity with an oxygen independent electron transfer. 
On one hand, GDH’s are oxygen independent but exhibit residual activities on 
various sugars. On the other hand, GOx’s are highly specific for β-D-glucose but 
naturally accept oxygen as electron acceptor substrate. Therefore, the right enzyme 
system needs to be selected in specific clinical application like during icodextrin 
application or during intensive care (see also chapter 1).  
The reengineered GOx V7 offers an oxygen independent alternative to WT GOx. V7 
is able to specifically detect β-D-glucose and to transfer electrons to a counter 
electrode without significant oxygen interference. Furthermore, V7 interacts on a high 
level with quinone diimine based mediators. With V7 it is first time possible to develop 
a glucose sensor which is absolutely specific for glucose, insensitive to blood 
components and can be applied at high oxygen levels. This allows accurate glucose 
monitoring under all the clinical conditions. Furthermore, V7 based sensors can also 
be applied in bio-engineering for the glucose determination in cell cultures, 
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independent from the oxygen contentment and the presence of other sugars. These 
insights will inspire researchers to reengineer GOx’s and other oxidoreductases for 
diagnostics and to develop implantable bio-fuel cells.  
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4. Investigation of mediator binding and further GOx 
optimization 
 
4.1 Purpose  
 
An intensive research on enzymatic glucose sensors took place with focus on the 
direct electrochemical communication between the enzyme and a signal transducer, 
ever since the first enzyme entrapped biosensor was introduced by Clark and Lyons 
in 1962 [115]. A great number of research reports are available to improve the electro 
chemical communication between the enzyme and the transducer component which 
can be divided in material science and protein engineering. The material science is 
focused on the modification of the enzyme-electrode interface and it has been shown 
that electrode modifications with for instance multi-walled carbon nanotubes or 
conductive polymers can significantly improve the electron transfer kinetics [116, 117] 
[118]. Protein engineering aims to optimize the enzyme towards specific needs and 
to gain knowledge about the involved mechanisms on a molecular level. GOx was 
mostly engineered to improve catalytic activity or enzyme stability [36, 39]. 
Engineering reports involving mediator compounds to improve the electrochemical 
communication comprises three reports. The GOx T30V I94V was found in a directed 
evolution campaign and attributes an increased kcat-value (from 69.5/s to 137.7/s) 
employing ferrocenemethanol as mediator component [40]. Horaguchi et al. (2012) 
reported a GOx with an 11-fold decreased oxygen activity found in a rational protein 
engineering approach [41]. Arango et al. (2013) employed a diabetes care relevant 
quinone diimine mediator system (N,N-bis[2-hydroxyethyl]-4-nitrosoaniline based) in 
a directed evolution campaign resulting in GOx-V7 which operates efficiently with the 
mediator component and exhibits a 37-fold decreased oxygen dependency [67]. The 
latter report of Arango et al. (2013) is described in detail in the chapter 3 of the 
present thesis. 
A challenge in the improvement of the electrochemical communication of GOx is the 
deep in the enzyme buried redox center. The mechanism of the electron transfer to 
the in the enzyme buried redox center is not known to date [57]. Since the enzyme 
operates naturally in aqueous solution, water soluble low molecular weight 
compounds such as quinone diimines or hexacyanoferrates are most commonly used 
in commercial available glucose sensors. GOX V7 was successfully improved for the 
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N,N-bis[2-hydroxyethyl]-4-nitrosoaniline based mediator system (QDM-1). An 
alternative quinone diimine mediator system is based on the nitrosoaniline N,N-bis(2-
hydroxyethyl)-2-methoxy-4-nitrosoaniline, which features a better solubility in 
aqueous solutions due to a higher polarity (named as QDM-2 in the whole thesis). 
The mediators were introduced in chapter 1.4.1. Both mediator systems are 
employed in diabetes care, whereby the higher solubility of QDM-2 is required for 
certain test stripe applications. Interestingly, GOx-V7 showed a much higher specific 
activity for QDM-1 compared with QDM-2. 
In order to assess the mediator binding mechanism and in order to further develop 
V7 towards an efficient use of QDM-2, computational studies as well as focused 
mutagenesis experiments were implemented. The results of the computational 
analysis were provided by the sub-group for computational biology of the chair for 
biotechnology (RWTH Aachen University, Dr. Marco Bocola).  
 
4.2 Strategy 
 
In chapter 3.3.2 it was shown that the mediator activity was improved by substitutions 
in position 414 and was discussed that it is very likely that the mediator binds in close 
vicinity to residue 414. The results were generated employing the QDM-1 system. 
The QDM-2 only differs from the QDM-1 by an additional methoxy group in position 
3, which leads to a more polar and sterically more demanding mediator component. 
The difference in the polarity and size between QDM-1 and QDM-2 makes this two 
mediator systems excellent candidates for the investigation of the mediator activity 
depending on the side chain chemistry of position 414. Ferrocenemethanol, a further 
example of a small water soluble mediator was included in the experimental studies 
as an additional control.  
The study for the investigation of the mediator binding and the further GOx 
optimization included the following activities: 
 Side directed mutagenesis of residue 414 to deduce a subset of amino acid 
residues which improve mediator activity. 
 Characterization of a selected GOx variant. 
 Molecular docking experiments to obtain a mediator binding model and to 
investigate the role of residue 414. 
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 Determination of theoretical electron transfer rates to obtain a quantitative 
mediator model and to support experimental data. 
 
4.3 Results 
 
4.3.1. Site directed mutagenesis and library screening 
 
The basis for the site directed mutagenesis study was V7 of which residue I414 was 
identified to play a major role in the mediator binding (see chapter 3.3.2). The 
QuikChange mutagenesis method was employed for the saturation of position 414. 
176 clones were screened employing the three mediator systems QDM-1, QDM-2 
and ferrocenemethanol (FM), yielding the four beneficial substitutions I414Y, I414M, 
I414V, I414L (Table 4-1). 
 
Table 4-1: Residual activities of variants after site saturation of position 414 in V7. Residue 414 was 
saturated using the QuikChange site directed mutagenesis method. The specific activities for four 
variants and references were determined in the respective mediator assays (2 M β-D-glucose; 8.9 mM 
QDM-1 / QDM-2 / FM). QDM-1/2: quinone diimine mediator 1/2; FM: ferrocenemethanol. 
 Residual activity [%] 
 QDM-1 QDM-2 FM 
V7 100.0±1.4 100.0±12.7 100.0±2.3 
WT 21.3±0.5 n.d  72.0±0.7 
V7-I141Y 52.4±1.6 813.9±54.2 108.8±7.2 
V7-I414M 9.8±0.5 627.6±39.3 53.1±10.7 
V7-I414L 15.3±0.5 230.6±15.1 40.1±3.1 
V7-I414V 9.7±0.4  328.8±24.2 24.5±2.5  
 
V7-I414Y showed a significant improvement for the more polar mediator QDM-2 (814 
% residual activity compared to V7) whereas the activity for QDM-1 decreased by 
almost 50% (V7: 49 U/mg; V7-I414Y: 26 U/mg). The FM activity for V7-I414Y 
remained close to V7 activity. V7-I414M was also improved for QDM-2 (628 % 
compared to V7) but showed only 9.8 % residual activity for QDM-1 and an around 
50% decreased activity for FM (compared to V7). A similar behavior was shown for 
V7-I414L and V7-I414V which are moderate improved for QDM-2 and decreased for 
QDM-1 and FM. V7-I414Y showed the highest improvement for the QDM-2 and 
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retains activity for FM. Therefore, V7-I414Y was selected for a detailed kinetic 
characterization. 
 
4.3.2  Kinetic characterization of V7-I414Y, V7 and WT 
 
GOx WT, V7 and V7-I414Y were expressed in S. cerevsiae ngd29 and subsequently 
purified. Purification and specific GOx quantification (employing ELISA) were 
executed as described in the material and method section. Enzyme reaction kinetics 
were recorded employing the QDM and FM assay (227.3 mM β-d-glucose) for 0-16.6 
mM QDM-1/2 and 0-10.9 mM FM. The enzymatic QDM-1 and QDM-2 conversions do 
not follow typical enzymatic Michaelis-Menten kinetics but showed an individual lag 
phase at low mediator concentrations due to the enzymatic pre-activation of the 
quinone diimine (from the corresponding p-nitrosoaniline) and the complex mediator 
chemistry. Furthermore, a saturation of GOx with the mediator compound could not 
be reached in some cases due to a limited solubility of the mediator in aqueous 
environment. Therefore, the kinetics were not analyzed according to a kinetic model, 
but the kinetic progressions were discussed qualitatively and the specific activities at 
certain mediator concentrations were compared. 
 
 
Figure 4-1: Kinetic progressions of V7, WT and V7-I414Y for the mediators QDM-1 (a), QDM-2 (b) 
and FM (c). The enzymatic kinetics were recorded at a fixed β-D-glucose concentration of 227 mM 
and for different mediator concentrations (QDM-1/2: 0 – 13.6 mM; FM: 0 – 10.9 mM). 
 
Figure 4-1-a) shows that V7 (for QDM-1 evolved) reaches the highest activity for 
QDM-1. At 13.6 mM QDM-1 the activity of V7 is 1.7 fold higher than of V7-I414Y and 
4.7 fold higher than of WT (V7: 55.9±1.6 U/mg; V7-I414Y: 33.2±0.4 U/mg; WT: 
12.0±0.1 U/mg). The saturation of V7-I414Y was not reached at 13.6 mM QDM-1 and 
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the progression of the kinetic indicates a low affinity of QDM-1 to V7-I414Y in 
compare to V7. The best performance for QDM-2 shows, with respect to activity and 
mediator affinity, V7-I414Y. The activity of V7-I414Y is at 13.6 mM QDM-2 4.8 fold 
higher than of V7 and 11.7 fold higher than of WT (V7: 2.7±0.1 U/mg; V7-I414Y: 
12.9±0.3 U/mg; WT: 1.1±0.6 U/mg). V7 and V7-I414Y show a similar behavior for 
FM, a slight difference can only detected in the saturation phase. GOx-WT seems to 
reach an inhibition after 3.6 mM FM. Nevertheless, V7-I414Y reached the highest 
activity for FM with 41.2±0.5 U/mg in compare to V7 with 35.8±0.2 U/mg and WT with 
13.5±0.1 U/mg at 10.9 mM FM. 
 
4.3.3 Mediator binding 
 
Molecular docking experiments were performed in order to elucidate the effect of 
substitutions in position 414 on the activity in the mediator assays. There is no 
previous prove of the mediator binding in the active site of the GOx or elsewhere. It is 
known that GOx can also interact with mediators of a size that the mediator cannot fit 
into the active site pocket and the electrons have to take long-range transfer routes 
through the enzyme [116, 117] [118]. Such electron transfer routes through GOx 
have been proposed [57] and therefore a simulation box of 50x50x50 Å, enclosing 
the complete GOx surface, has been employed in the first molecular docking stage 
with respect to all possible binding modes on the surface and the inner cavities of the 
enzyme. The mediator force field preparation and docking performance is described 
elsewhere [112]. The best binding energies for the applied mediators (QDM-1 and 
QDM2 as the corresponding quinone diimines) were found in the active site cavity. 
Additional dockings were performed for all variants with a simulation box of 25x25x25 
Å centered in the active site. Figure 4-2 shows the considered binding mode on the 
examples of QDM-1 in V7 and QDM-2 in V7 I141Y. 
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Figure 4-2: Docking poses of QD-mediators in the active site of GOx. a) Active site setup of V7 in 
combination with QDM-1; b) V7 –I414Y in combination with QDM-2 (ball and stick representation). 
Figure after A. Bălăceanu 2013 [112]. 
 
Figure 4-2 shows that the QM-mediators bind in the active site in distances of 
approximately 3.5 Å from the N5 atom of the FAD and in a very close vicinity to the 
residue of interest in position 414. The GOx-mediator complexes were neutralized, 
solvated in water and energy minimized [112]. These starting structures were 
subjected to molecular dynamics simulations over 5 ns. Table 4-2 shows the average 
force field energies of the mediators in the active site obtained from the MD-
simulations. 
 
Table 4-2: Average energies of QDM-1 and 2 in GOx WT, V7 and V7-I414Y over 5 ns [112]. 
 QDM-1 QDM2 
 WT V7 V7-I414Y WT V7 V7-I414Y 
Energy 
[kJ/mol] 
104.7 105,2 109.3 161.7 165.3 153.0 
 
The average energy of the QDM-2 is with 153 kJ/mol for V7-I414Y significant lower 
than for WT and V7, what is in qualitative accordance with the experimental results. 
For QDM-1 an opposite trend is observed, WT and V7 perform equally and V7-I414Y 
shows a bad energy. In the experimental results V7 shows significant higher catalytic 
activities with the QDM-1 than with the QDM-2. Since the differences in the catalysis 
cannot be explained quantitatively by assessing only the mediator energies, 
theoretical electron transfer rates (ETR) using the Markus theory were calculated. 
a) V7 / QDM1 b) V7-I414Y / QDM2
QDM-1 QDM-2
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The ETR calculations estimate the reorganization energy upon instantaneous 
electron transfer dependent on the distance and coupling to FADH- . Tab. 4-3 
summarizes the calculated ETR’s for WT, V7 and V7-I414Y in combination with 
QDM-1 and QDM-2. 
 
Table 4-3: Calculated electron transfer rates for WT, V7 and V7-I414Y in combination with QDM-1 and 
QDM-2 [112]. 
 QDM-1 QDM2 
 WT V7 V7-I414Y WT V7 V7-I414Y 
ETR 0.15 0.32 0.28 0.04 0.13 0.25 
 
As expected, the WT shows the lowest ETR for both of the mediators. For V7 the 
ETR is significantly higher for QDM-1 than for QDM-2 what is also in good 
accordance with data from the catalysis. Similar ETR were recorded for V7-I414Y for 
both mediators, what is also going hand in hand with experimental data with respect 
to specific activities (see chapter 4.3.2). 
 
4.4 Discussion 
 
The electrochemical communication between the redox center of GOx and electrode 
systems are of high interest not only for glucose sensing but also for bio-fuel cells. 
While the electron transfer in biofuel cells does not necessarily need to be very 
specific. However, in glucose sensing a highly specific electron shuttling between the 
redox center and the transducer of the sensor is absolutely mandatory to ensure an 
accurate glucose determination. For GOx it has been shown that electrons can be 
accepted by large mediators like polymers or multi-walled carbon nanotubes (which 
cannot enter the active site) and by small water soluble compounds like ferrocene or 
quinone diimine derivates (which can enter the active site) [64] [3] [116, 117] [118]. 
There are proposals for electron travel routes through the enzyme (from the active 
site to the surface) and there is a report in which surface substitutions over the whole 
enzyme showed an increase of a direct electron transfer [57] [96]. However, a 
specific binding mode of a mediator component in the redox center or on the surface 
of GOx was never shown. Furthermore, it has never been shown that the mediated 
electron shuttling can be adjusted for a specific mediator by single amino acid 
substitutions. 
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In the previous chapter of this thesis it was shown that substitutions of reside 414 
allow the improvement of the mediator activity employing a quinone diimine mediator 
which is based on the nitrosoaniline N,N-bis[2-hydroxyethyl]-4-nitrosoaniline (see 
Tab. 3-1). In the extension of the study we could even show that a change in the 
chemistry of the residue 414 led to a change in the preference of polarity and size of 
the mediator. So was the activity for the more polar QDM-2 improved through the 
substitutions I414Y, I414M, I414L and I414V in V7 (see Tab. 4-1). Interestingly, the 
same substitutions caused drastic decrease in the mediator activity with the less 
polar QDM-1. Ferrocenemethanol (FM) was employed as control for a small 
molecular weight mediator and the substitutions I414M, I414L, I414V also 
significantly decreased the mediator activity, similar to the results of the QDM-1 (see 
Tab. 4-1). The results indicate that the mediator activity is directly influenced by 
residue 414. 
Since the biggest difference was found between QDM-1 and QDM-2 though the 
substitution I414Y, the variant V7-I414Y was produced in a 10 L fermentation scale, 
purified and subsequently subjected to a characterization by kinetic analysis. The 
specific activities showed that the highest turnovers are still reached by V7 in 
combination with the QDM-1. However the activity of V7 was increased by 4.8 fold for 
QDM-2 through the substitution I414Y. This variant V7-I414Y shows a drop in activity 
for the QDM-1 from 56 to 33 U/mg. The enzymatic kinetic clearly indicates a loss in 
affinity for the mediator QDM-1 through the substitution I414Y. In this specific case it 
seems that the more polar mediator QDM-2 prefers the more polar residue tyrosine 
rather than the aliphatic, non-polar isoleucine. However, the effect by residue 414 
cannot be narrowed down to polarity since the aliphatic methionine and leucine and 
valine show similar effects than thyrosine. Conformational changes need therefore 
also be considered. 
Molecular docking studies elucidated that the QDM-1 and the QDM-2 bind preferable 
directly in the active site of GOx 3.5 Å away from the N5 atom of the FAD and in 
direct vicinity to residue 414. A clear distinction between the mediators and the 
different variants was not possible but it was first time shown that small molecular 
weight mediators bind directly in the active site. The direct vicinity of the mediator 
binding site to the residue 414 allows the conclusion, that the substitutions in position 
414 influence directly the mediator binding. 
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The theoretical electron transfer rates were calculated according to the Marcus-
Theorie and were in good accordance with the catalytic data received during variant 
characterization (see Tab. 4-3). A. Bălăceanu 2013 [112] concluded that small 
fluctuations in the reorganizational energy term lied to significant changes of the 
reaction rates. The reorganizational energy term describes in the Marcus theory the 
re-structuring of the molecules and the surrounding environment ahead of the actual 
electron transfer. Substitutions of the residue 414 could reorganize the active site to 
minimize molecular reorganization during charge transfer and ensure thereby a more 
effective electron transfer with QDM mediators. 
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5. Bio-process development 
 
5.1 Purpose 
 
A prerequisite for a successful directed evolution campaign is the availability of 
suitable up- and downstream protocols for the respective protein in order to 
characterize and compare variants in detail. The bioprocess development often turns 
out to be a challenge in directed protein evolution due to altered protein properties 
such as surface chemistry, structural properties or functional properties. 
GOx is widely used in industry and several host organisms are described for 
recombinant GOx production [119-124]. Within the present directed evolution 
campaign the glyco-engineered S. cerevisae strain ngd29 (see chapter 1.6) was 
selected in order to ensure the production of homogeneous GOx molecules by the 
reduction of the high-mannose N-glycosylation of [Man]n[GlcNac]2 to a uniform 
structure of [Man]8[GlcNAC2]. The ngd29 mutant in fact leads to a uniform N-
glycosylation pattern but the cells also suffer from a changed cell wall morphology 
combined with slow growth rates. Furthermore, no fermentation protocols are 
published for the S. cerevisiae ngd29 strain and no purification protocols for hypo-
glycosylated GOx are available. 
An establishment and an optimization of up- and downstream protocols took place in 
order to produce GOx in a sufficient quantity and quality for detailed enzyme 
characterizations. Parts of the process establishment were accomplished and 
published within the master thesis of Meena Reit [125]. 
 
5.2 Strategy 
 
For the production of several GOx-variants and controls simple and fast protocols 
should be established. To reach the goal in a certain time frame existing protocols 
were consulted and supportively used to meet predefined objectives. The strategy for 
the development of the up-stream protocol can roughly be divided in the three 
following activities: 
 Media screening 
 Investigations for possible feeding strategies 
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 Process characterization 
 
The establishment of the downstream process was based on the process described 
in the dissertation of Ziwei Zhu [43]. The process development included the following 
steps: 
 Establishment of an primary separation step by Cross-Flow-Filtration (micro-
filtration) 
 Establishment of an ultra- / dia-filtration step by Cross-Flow-Filtration (ultra-
filtration) 
 Investigation of hydroxyapatite as potential chromatography resin (data not 
shown) [125] 
 Optimization of a Anion-exchange chromatography as the major purification 
step 
 
5.3  Results 
 
5.3.1 Up-stream processing 
 
5.3.1.1 Media-screening 
 
Three yeast cultivation media were selected for comparison. The complex YPD-
media, the semi-synthetic SC-U media and a full synthetic media called SynY (for 
media compositions see material and methods). The YPD media is probably one of 
the most common yeast media used in molecular biology and also finds its 
application in industrial processes [126]. SC-U media is based on the yeast nitrogen 
base media and was described to be suitable for the S. cerevisiae strain from 
Invitogen (SC. INV) [127]. The SynY media is fully synthetic and was established 
based on a published protocol [128]. 
For the comparison of the selected media S. cerevisiae was cultivated in small-scale 
batch fermentations and the produced bio-mass (OD600) and the GOx-activity (ΔE/h, 
QDM-1detection system) were used for the assessment of the different media (Figure 
5-1). The GOx activity was thereby a measure for the GOx expression. 
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Figure 5- 1: Media comparison in respect to cell growth and GOx-expression. Sc. ngd29/pYES-GOx 
V7 was cultivated in small scale bioreactors for 48 h in YPD-, SC-U- and SynY-media. The optical 
density of the cell broth was determined and clarified supernatants were subjected for GOx-activity 
determination employing the QDM-1 assay. YPD media: yeast extract, peptone, dextrose media; SC-U 
media: Saccharomyces cerevisiae without uracil media; SynY media: synthetic yeast media. 
 
Moderate cell growth was observed with the complex YPD-media (OD600~16) 
combined with an easy media preparation. Unfortunately the YPD-media exhibits a 
brownish color which becomes strengthened after cell harvest and which strongly 
impairs the GOx mediator assay and the ABTS assay (data not shown). The SC-U 
media does not impair the activity assays but the cell growth was approximately 50 % 
less (OD600~8) and the GOx expression was significant lower (YPD: 94 (ΔE/h)/mL; 
SC-U: 8 (ΔE/h)/mL). However, a good cell mass formation and the best GOx 
expression was observed for the SynY media (OD600~15; 250 (ΔE/h)/mL), which 
also does not show any brown stain. The SynY media was selected for further 
investigations accordingly. 
 
5.3.1.2 Feeding strategy  
 
In the selected expression system, the expression of the heterologous GOx gen is 
controlled by the GAL1-promoter which is repressed in the present of β-D-glucose 
[129]. It is assumed that the gene transcription is induced in case of β-D-glucose 
limitation and in the present of galactose [113, 114]. For the assessment of the 
galactose feed two different fermentations were compared. Fermentation one took 
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place in SynY-media (1% β-D-glucose) without galactose (Fermentation A). 
Fermentation two took place in YPD-media (1% β-D-glucose) and D(+)-galactose 
was added after 22 h (3% w/v) and 49 h (1% w/v) (Fermentation B). Figure 5-2 
shows the GOx-activity (ΔE/h, QDM-1 assay) as an indicator for the GOx expression 
for both fermentations. 
 
 
Figure 5-2: GOx expression with and without D(+)-galactose. Sc. ngd29/pYES-GOx V7 was cultivated 
in small scale bioreactors in SynY-media (Fermentation A) and YPD-media (Fermentation B). 
Fermentation B was supplemented with D(+)-galactose after 22 h (3 % w/v) and after 49 h (1 % w/w). 
The GOx activity was determined as an indication for the GOx expression (QDM-1 assay).  
 
After 17 h (fermentation without D(+)-galactose) and after 19 h (fermentation with 
D(+)-galactose) no β-D-glucose was detectable anymore in cell supernatants. As 
figure 5-2 shows, a strong increase in GOx-activity can be observed in both 
fermentations (up to 3.2 ΔE/h Fermentation A; up to 2.4 ΔE/h Fermantation B). After 
a strong initial expression in Fermentation A between fermentation hour 20 and 25 
the expression stagnated almost completely. In Fermentation B a slight increase in 
GOx-activity was observed after the initial expression phase. However, the 
expression in Fermentation B seems to be independent of from the D(+)-galactose 
since the initial expression takes place before the first feed and also no significant 
increase in GOx-activity could be observed after the second D(+)-galactose feed. 
 
β-D-glucose represents the major substrate of GOx. The presence of β-D-glucose in 
cultivation media which also contains GOx leads to production of hydrogen peroxide 
what may influence cell growth. Furthermore, β-D-glucose represses the GAL1-
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ptomotor which controls the expression of GOx in the selected expression system. 
For those two reasons glycerol was selected to implement an alternative carbon 
source. The glycerol feeding approach was based on a previous study [130]. To 
assess the glycerol utilization of Sc ngd29 two fermentations in SynY-media were 
executed. 1 % β-D-glucose was present in both fermentations as a growth initiator. In 
Fermentation-1 glycerol was added controlled by the pH. Therefore, a mixture of 80 
% glycerol / 1.5 % ammonia was used as base-feed for regulating the pH in 
Fermenter-1. In Fermentation-2 the glycerol was replaced by water. Figure 5-3 shows 
the quantitative glycerol progression as function of the fermentation time (The 
determination of the glycerol concentration was executed by the “Lehrstuhl für 
Bioverfahrenstechik” - RWTH AachenUniversity, the method is described elsewhere 
[125]) 
. 
 
 
Figure 5-3: Glycerol consumption during fermentation of Sc ngd29/pYES-GOx V7.  The cultivations 
took place in small scale bioreactors for 48 h in SynY-media 2% glycerol. The base-feed in 
Fermentation-1 was supplemented with glycerol (80 % glycerol / 1.5 % ammonia) for a pH controlled 
glycerol addition. The glycerol concentration was monitored applying HPLC as an indication for the 
glycerol consumption. 
 
The glycerol concentration in Fermentation-2 remained at approximately 2 % during 
the entire fermentation, which indicates that no glycerol was metabolized by Sc 
ngd29. In Fermentation-1 an increase of glycerol was observed during fermentation. 
The observed glycerol concentrations during Fermentation-1 corresponded to the 
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added amount of glycerol during pH control, which also indicated that Sc ngd29 did 
not metabolize glycerol in the selected fermentation setup.  
 
5.3.1.3 Process characterization 
 
Based on the previous results a final fermentation protocol was implemented. The 
protocol describes a fermentation process in SynY-media with 1% β-D-glucose and 2 
% glycerol over 42 h, the protocol details are described in chapter 2.2.13. For better 
understanding of the fermentation process a 2 L-characterization run was executed 
using exhaust gas analysis. The following parameters were used for the fermentation 
assessment: 
 β-D-glucose concentration  
 acetate content1) 
 pO2 
 optical density (indicator for cell growth) 
 growth rate 
 GOx activity (indicator for GOx expression) 
 Respiratory quotient (RQ) (indicator for metabolic activity) 
1) The determination of the acetate concentration was executed by the “Lehrstuhl für 
Bioverfahrenstechik” (RWTH AachenUniversity), the method is described elsewhere [125]. 
 
The growth rate was calculated based on cell dry mass and the fermentation time 
according to the following equation: 
 
              
          
      
 
 
X: cell dry weight [g/mL] at fermentation time t 
X0: cell dry weight [g/mL] at fermentation time t0 
t: fermentation time [h], end of the growth phase 
t0: fermentation time [h], beginning of the growth phase 
 
The RQ was calculated based on the O2 and CO2 content of the exhaust gas 
according to the following equation: 
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Figure 5-4 shows the progression of selected fermentation parameters as functions 
of the fermentation time. 
 
 
Figure 5-4: Batch-fermentation of the expression system Sc ngd29/pYES-GOx V7. The 
cultivations took place in a small scale bioreactor (2 L) for 48 h in SynY-media 2% glycerol. The 
fermenter was inoculated by a shaking flask culture (SynY-media) with 5% of the total 
fermentation volume. The whole cultivation procedure is described in chapter 2.2.13. Online 
monitoring: pH, pO2, exhaust gas analysis (O2 / CO2); Offline monitoring: GOx activity, optical 
density, β-D-glucose, acetate, cell dry weight. 
 
As indicated on the top of figure 5-4 the fermentation can be divided in four different 
phases which will be individually described in the following. 
 
Lag-phase: 
During the lag-phase the cells adapted to the new environment, no metabolic activity 
was detected. During this phase, the GOx expression was repressed by the presence 
of β-D-glucose. 
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First growth phase: 
Between fermentation hour 6 and 12 the cells consumed the available β-D-glucose 
and the pO2 of the fermentation broth dropped significantly. The RQ reached a value 
of 3.4 which indicates a higher CO2 production than O2 consumption, before it 
dropped to values smaller 1 (after 11 h). In this phase the cells show a typical 
exponential growth phase with µ=0.4 h-1. The GOs-activity increased only slightly and 
the cells started to produce acetate. 
 
Expression phase: 
Between fermentation hour 12 and 25 a strong increase in the GOx activity was 
observed reaching a value of 6.5 ΔE/h (QDM-assay). Also the acetate metabolism 
took place in this phase. The acetate value reached its maximum with 0.33 g/L at 
around 16 h and started to decrease again afterwards. At acetate concentrations 
higher than 0.2 g/L the formation of cell mass stopped almost completely (12.7h – 
13.4 h). The RQ remained at values smaller 1. 
 
Second growth phase: 
After the acetate concentration reached values smaller 0.2 g/L a second cell growth 
phase with µ=0.07 h-1 was observed. 
 
After the second growth phase the cell growth and the product formation stagnated. 
The metabolic activity also decreased after fermentation hour 25, indicated by an 
increase of the oxygen content of the fermentation broth. 
 
5.3.2 Down-stream processing 
 
5.3.2.1 Primary separation and ultra / dia-filtration 
 
Initially, the downstream process was adopted for the handling of larger volumes 
after 10 – 20 L fermentations. Therefore a tangential flow filtration system (TFF) was 
introduced for concentration of the intermediated after cell harvest and for the buffer 
exchange before purification (for the principle of TFF and for implementations see 
materials and methods chapter). A Hydrosart® ultra-filtration cassette (sartorius 
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stedim biotech) with a membrane area of 0.1 m2 and a cut-off of 10 kDa was ued. A 
dia-filtration set up was chosen in which first a concentration step took place, 
followed by the buffer exchange. 
A GOx specific TFF performance optimization took place under the professional 
supervision of an application specialist (sartorius stedim biotech). Therefore, the 
permeate flow was optimized dependent on the transmembrane pressure (TMB) 
(data not shown). In the final setup a TMB of 1.5 bar (1 bar feed pressure, 2 bar 
retentate pressure) was employed and seven dia-filtration volumes were performed 
for the buffer exchange. 
In the further development the TFF system was also applied for cell harvest (before 
ultrafiltration) Therefore the cells were retained in the retentate and the GOx 
containing cell supernatant was collected in the permeate. A microfiltration 
membrane with a maximum pore size of 0.45 µM and a membrane area of 0.1 m2 
was applied (Hydrosart® 0.45 µm, sartorius stedim siotech). 
 
5.3.2.2 Anion-Exchange Chromatography (AEC) 
 
In Zhu 2006 Anion-Exchange Chromatography (AEC) and Hydrophobic-Interaction 
Chromatography (HIC) were applied as purification steps after cell separation and 
buffer exchange. Both separation steps were in a first trial also applied for the 
purification of GOx-V7 expressed in Sc ngd29. The AEC was carried out using a 50 
mM sodium phosphate buffer (pH6) for equilibration and washing and 1 M sodium 
chloride for elution. The GOx-elution fraction from the AEC was complemented with 
ammonium sulfate (1.5 M) before loading the HIC column. The HIC was carried out 
with a 50 mM potassium phosphate- / 1.5 M ammonium sulfate buffer (pH 6) for 
washing and a 1 mM potassium phosphate buffer (pH7) for elution. A linear gradient 
was applied for elution in both chromatography steps. The execution of the AEC 
(after optimization) is described in detail in the material and method section. The 
initial protocol for the AEC and the protocol for the HIC are described elsewhere [43]. 
Figure 5-5 shows the respective SDS-PAGE’s of the collected elution fractions. The 
fractions for SDS-PAGE analysis were selected by the GOx activity (QDM-1 
detection system). 
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Figure 5-5: SDS-PAGE analysis of GOx containing fractions after AEC and HIC. The GOx containing 
elution fractions after column chromatography were subjected to SDS-PAGE analysis. The SDS-
PAGE was carried out under reducing conditions on a 10% acryl amid gel. The GOx content of the 
fractions was determined employing the QDM-1 assay (data not shown). a) Elution fractions of the 
AEC. b) Elution fractions of the HIC. The GOx-band was expected at approximately 100 kDa, black 
box. 
 
Figure 5-5 a) shows that an enrichment of GOx-V7 took place during AEC (at 100 
kDa, black box). However, also a high content of impurities was detected. A 
significant enrichment of proteins at around 55 kDa and 130 kDa is shown in figure 5-
5 a). All fractions (F20 – F28) contained GOx according to the GOx activity assay and 
were polled for further processing by HIC. The content of the impurities at 55- and 
130 kDa were used for the assessment of the HIC performance. As figure 5-5 b) 
shows, the impurity at 55 kDa could be depleted during HIC. However the unspecific 
protein at 130 kDa was even more enriched and showed after HIC higher quantities 
than the GOx fractions. Furthermore a 70 kDa protein band was enriched after HIC. 
 
In order to achieve pure GOx and to establish an efficient and simple purification 
process, the AEC was optimized with respect to the elution conditions. The AEC was 
thereby executed like described above since the GOx binding was proven, only the 
linear elution gradient was replaced by a step gradient. The purpose of this 
optimization was the determination of the exact wash buffer / elution buffer ratio for a 
specific GOx elution. In a first approach the design of the elution gradient defined a 
step wise increase of the elution buffer content by 0.5 % beginning from 0 % until the 
GOx elution took place. Each step was performed for 1.5 column volumes (CV) (data 
not shown). In a second approach an optimized step gradient for specific GOx elution 
was established. Table 5-1 summarizes the elution gradient after optimization. 
F20 .- F28: Elution fractions AEC (15 µL each)
M: Protein molecular weight standard
M        F20      F21     F22     F23     F24      F25      F26      F27     F28 M         F14       F15       F16       F17       F18       F19    
F14 .- F19: Elution fractions HIC (15 µL each)
M: Protein molecular weight standard
a) b)
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Table 5-1: GOx elution profile after AEC optimization. The elution gradient of the AEC was optimized 
towards a specific GOx elution. Wash 1: elution of unspecific proteins; Wash 2: elution of unspecific 
proteins; Elution of GOx: elution buffer concentration for specific GOx elution; Regeneration: first 
column regeneration before NaOH treatment. 
Amount NaCl 
(eluition buffer) [%] 
Step length 
(CV) 
Purpose 
1 1.5 Wash 1 
5 3 Wash 2 
7.5 1.5 Elution GOx 
7.5 - 100 1 Regeneration 
 
Figure 5-6 shows a typical elution profile of the optimized AEC. The chromatogram 
also includes the GOx activities determined in the respective elution fractions (gray 
bars). The marked starting points of the gradient step are theoretical calculated 
considering the death volume from the gradient valve to the column exit. 
 
 
Figure 5-6: AEC elution chromatogram after optimization. The AEC elution gradient was optimized 
towards a specific GOx elution. The absorbance was monitored at three different wavelengths (215-, 
254-, 280 nm). The different gradient steps are marked in the chromatogram (black bars). The GOx 
activity was determined for all collected fractions and indicated in the graph in [ΔE/h] (gray bars).The 
final AEC method is described in detail in the material and method section. 
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Figure 5-6 represents the chromatogram after the first column wash. The absorption 
at 215 nm started to increase slightly between 220 min and 253 min after the 5% 1 M 
NaCl gradient reached the column. In these phase mostly impurities were eluted from 
the column. Between 255min and 265 min the absorption signal shows a double 
peak with two maximums, one with 900 mAu and one with 800 mAu. The double 
peak was followed by two broad single peaks. The double peak and the two broad 
peaks corresponded to the 7.5% 1 M NaCl gradient step. The fractions in which GOx 
activity was detectable are marked in the chromatogram (grey bars). The fractions of 
the first maximum of the double showed the highest GOx activity. The fractions with 
the highest activity were first analyzed by SDS-page (Figure 5-7 a) and afterwards 
pooled. The pool was concentrated and re-buffered (50 mM KxPO4, pH7) by 
ultracentrifugation. The purity of the pool after the optimized AEC step was compared 
to the purity of the pool after AEC and HIC of the old protocol (Figure 5-7 b). 
 
 
Figure 5-7: SDS-PAGE analysis of GOx containing samples. a) Elution fractions after the optimized 
AEC with the highest GOx content. b) Pooled elution fractions after the AEC /HIC sequence (old 
protocol) and after the optimized AEC. The SDS-PAGE was carried out under reducing conditions on 
a 10% acryl amid gel. The GOx activity of the fractions was determined employing the QDM-1 assay. 
The GOx content was determined employing a GOx specific ELISA. 
 
Elution fractions 66 - 70 of the optimized AEC exhibit a dominant protein band at 
around 100 kDa, which are identified as GOx-V7 (Figure 5-7 a, black box). The 
strongest GOx bands are the ones from fractions 67- 69 what is in accordance with 
the results presented in the chromatogram (Figure 5-6). Only slight impurities could 
be identified at around 70- and 55 kDa. To assess the improvement of the AEC in 
M          F66        F67      F68       F69       F70     
F66 - F70: Elution fractions AEC (15 µL each)
M: Protein molecular weight standard
M            1                         M             2     
1: 10 µG GOx-V7 after AEC and HIC
2: 10 µG GOx-V7 after optimized AEC 
M: Protein molecular weight standard
a) b)
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compare to the two chromatography-step process (AEC / HIC), pooled fractions from 
both processes were compared (Figure 5-7 b). While the pool of the old two-step 
process shows significant impurities at 70- and 130 kDa, the pool of the optimized 
one chromatography-step process exhibits only the GOx as a dominant band and 
very weak bands at 70- and 55 kDa. 
 
5.4 Discussion 
 
5.4.1 Media screening and feeding strategy 
 
Three different media were tested for the cultivation of the expression strain Sc 
ngd29/pYES2-GOx, the complex YPD-media, the minimal SC-U media and a 
synthetic media called SynY. The SynY media is fully synthetic and was established 
based on a published protocol [128]. The YPD-media showed the best bio-mass 
formation, followed by the SynY- and the SC-U media in small scale fermentations 
over 48 h. However, the best product formation was achieved employing the SynY-
media (SynY: 250 (ΔE/h)/mL; YPD: 94 (ΔE/h)/mL; SC-U: 8 (ΔE/h)/mL; (ΔE/h)/mL: 
enzymatic activity as a measure of the product formation). Furthermore, the activity 
assay for GOx was not influenced by media components after enzyme purification in 
case of the SynY but in case of the YPD (due to the formation of a dark brown dye – 
unidentified). The synthetic SynY-media was selected for the further investigations. 
The media properties regarding the better formation of bio-mass and product might 
be traced back to the defined composition of the media in which the nutrient 
composition and concentration is adjusted to the needs of the host organism. 
Furthermore, the components of the media are available in a pure form and do not 
need to be cleaved from macro-molecules, what accelerates and simplifies the 
metabolism of the host organism. 
The expression of the GOx gen was under control of the GAL1-promoter and the 
influence of a galactose induction was investigated. The comparison of two different 
fermentations showed that the addition of galactose to the cell culture does not show 
a clear influence on the GOx expression. Accordingly, no galactose feed was applied 
in further fermentations. The GAL1 promoter is repressed in the presence of glucose 
and induced by the presence of galoactose [113, 114]. However, a model for the 
induction in the absence of galactose was already reported [131]. In the latter report 
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a model was proposed in which activation by high levels of the GAL1 protein or GAL3 
protein does not involve galactose. 
 
Since the GAL1 promoter is repressed in the presence of glucose the GOx 
expression during the cultivation only starts after the initial glucose in the media is 
almost complete metabolized. Therefore, no additional glucose was added to the 
culture to ensure the GOx expression after the initial growth phase. To improve the 
formation of biomass after the initial growth phase and also to increase the GOx 
yield, glycerol was added to the media as additional carbon source. Glycerol was 
chosen as a carbon source which does not repress the GAL1 promoter and which 
was already successfully applied for the cultivation of S. cerevisiae [130]. With two 
fermentations over 48 h it was shown that no glycerol was utilized by Sc. ngd29 
under selected conditions (see chapter 5.3.1.2). A diauxic growth was observed 
during fermentations under the selected conditions employing the host Sc. ngd29 
(see chapter 5.3.1.3). In a diauxic growth the cells always metabolize first the energy 
richest carbon source, which is glucose. After the utilization of the glucose the cells 
might prefer ethanol instead of glycerol since it was shown that the achieved growth 
rates of a S. cerevisia strain are higher on ethanol than on glycerol (ethanol: µmax=0.2 
h-1; glycerol: µmax=0.01 h
-1) [132, 133].  
 
5.4.2 Fermentation analysis 
 
A 2 L fermentation was executed for the assessment of the upstream process. The 
process could be divided in the four different phases; the lag-phase, the initial growth 
phase, the expression phase and the second growth phase. Almost no metabolic 
activity was observed during the lag phase in which the cells adopt to the 
environment and the GOx expression is repressed through the presence of glucose. 
 
A typical exponential growth was observed between fermentation hour 6 and 12 with 
µ=0.4 h-1. During this first growth phase an increase of the RQ value up to 3.4 were 
observed what indicated the formation of components like ethanol and acetate. It is 
very likely that this phenomenon appeared due to the Crabtree-Effect in which 
anaerobe metabolism is observed, next to the respiratory [134]. The Crabtree-Effect 
 
Bio-process development 80 
would also explain the formation of acetate which started in the first growth phase 
and reached its maximum with 0.33 g/L after 14 h during the expression phase. 
 
The expression phase started after 12 h initiated by an almost complete utilization of 
the glucose. Accordingly to the glucose repression of the GAL1 promoter, the GOx 
expression started after glucose utilization and remained constant until fermentation 
hour 25 was reached. With the complete utilization of the glucose the oxygen value 
showed a diauxic shift that indicates that the cells switched to an alternative carbon 
source, which could be acetate or ethanol. The sudden drop down of the RQ to 
values smaller 1 supports this theory since high amounts of oxygen are necessary for 
the utilization of reduced substrates. As already mentioned a formation of acetate 
took place during the first growth phase and the expression phase. While the acetate 
concentration exceeded a value of 0.3 g/L the biomass formation stagnated, what 
resulted in the separation between the first and the second growth phase. The cell 
growth was most likely inhibited by the high acetate concentration during growth 
phase 1 and 2. In literature it was shown that acetate concentrations from 0.05 to 0.1 
% w/v act as a stress factor for yeast cells [135]. After the acetate concentration went 
below 0.2 g/L a diauxic shift was observed and the formation of biomass continued 
with µ=0.07 h-1 until fermentation hour 25, after which another diauxic shift was 
monitored. A possible explanation could be the switch to ethanol as the carbon 
source, assuming the previous carbon source was acetate. After 25 h, the biomass 
formation as well as the GOx expression stagnated probably due to the switch to a 
less favorable carbon source. 
A simple batch-fermentation protocol was successfully established based on the 
glyco-engineered strain Sc. ngd29, for which not fermentation protocol was reported. 
The obtained GOx yield was sufficient for the executed GOx characterization studies. 
Anyhow, a further optimization of the process would be necessary with respect to the 
GOx yield in order to produce sufficient quantities for instance for electrochemical 
GOx characterizations and for diabetes test stripe experiments. 
 
5.4.3 GOx purification 
 
The introduction and optimization of A TFF system made the production of the GOx 
at pilot scale feasible. The TFF system replaced the cell harvest by centrifugation in 
 
Bio-process development 81 
several batches and the product concentration and the buffer exchange by death-end 
filtration and/or dialyses. The implemented TFF unit operations allowed a primary 
separation of up to 20 L cell culture within one day, including cell separation, volume 
reduction (≥30-times) and buffer exchange. Furthermore, the volume reduction and 
buffer exchange can be performed under aseptic conditions employing a closed TFF-
system. 
The intermediate after primary separation was subjected to column chromatography 
for the actual product purification. A two chromatography step process was applied 
including anion exchange chromatography (AEC) and hydrophobic interaction 
chromatography (HIC). The protocol was successfully applied in the directed 
evolution experiment by Zuh 2006 [43]. The SDS-page analysis showed that three 
different protein fractions were enriched after the AEC (first step), one at 55 kDa, one 
at 100 kDa and the third one at 130 kDa. Activity analysis of the different fractions 
showed that only the 100 kDa band belongs to GOx. Both impurities (55 kDa, 130 
kDa) were also enriched after the HIC. The analysis clearly shows that the available 
protocol is not applicable for the GOx expressed in Sc. ngd29. A possible explanation 
might be the altered glycosylation pattern by the Sc. ngd29 strain. Especially the 
interaction with the resin of the AEC can be significantly changed due to the less 
carbohydrate content. The high carbohydrate content of the GOx expressed in the 
Sc. INV strain probably covers a certain portion or the surface charge what would 
lead to a weaker interaction with the AEC resin. 
The SDS-page analysis of the collected chromatography fractions showed the GOx 
band and the bands of the impurities eluate time-displaced from the AEC column, 
what is not the case for the HIC in which all three proteins eluate at the same time 
(Fig. 5-5). The optimization of the AEC resulted in two washing steps, one with 1 % 
elution buffer (1 M NaCl), one with 5 % elutionbuffer and a subsequent elution step 
with 7.5 % elution buffer. The comparison of optimized AEC with the the old protocol 
(AEC + HIC) shows that the single AEC (optimized) is able to deplete the impurities 
at 55- and 130 kDa, what was not possible with the old two step protocol. The purity 
reached with the optimized AEC was estimated to be higher than 90 % and sufficient 
for the characterization of GOx variants. The purity with only the AEC step was 
reached by stepwise determination of the exact elution point of hypo-glycosylated 
GOx (with respect to the ratio wash to eleution buffer). Most likely, the impurities 
eluate from the column during the first and the second wash step, while the GOx is 
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still retained by the resin. In the final protocol the AEC was only followed by an 
additional concentration- and buffer exchange step (depth filtration in spin-columns). 
Figure 5-8 shows an overview of the established downstream process for hypo-
glycosylated GOx.  
 
 
Figure 5-8: Overview of the GOx downstream process after optimization. The process comprises 
of four unit operations and can be divided in the three parts primary separation, purification and 
polishing. 
 
A simple and fast downstream process was successfully implemented comprising the 
four unit operations cell separation, volume reduction / buffer exchange, AEC and 
final concentration / buffer exchange. The process delivers samples with a GOx 
content higher than 90 % and can be executed within two days. The latter two 
attributes make the established downstream process ideal for the characterization of 
GOx variants. 
Cell separation by TFF
Volume reduction / 
buffer exchange
Anion exchange 
chromatography
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buffer exchange
Primary separation
Purification
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6. Summary and Conclusion 
 
The present study was divided in three parts: 1) the engineering of GOx for less 
oxygen sensitivity and improved mediator activity; 2) Investigations for the mediator 
binding and further improvement of GOx towards the employment of different 
mediator systems and 3) the establishment of a bio process for the fast and 
reproducible production of pure GOx.  
In the first project part a mircrotiter-plate screening system was established, suitable 
for the employment of p-nitrosoaniline based mediators. The screening system was 
successfully used for the screening of eleven mutagenesis libraries. The four novel 
positions 173, 332, 414 and 560 were identified in random mutagenesis libraries. Site 
saturation studies revealed that position 560 is a key residue for oxygen sensitivity, 
that positions 173 and 332 increase mediator and oxygen activity, and that position 
414 influences mediator activity and increases or reduces oxygen activity depending 
on the substitution. Simultaneous site saturation by OmniChange allowed the 
consideration of cooperative effects between the four identified positions and resulted 
in GOx V7. V7 showed a 37-fold reduced oxygen dependency by maintained β-D-
glucose specificity and thermal resistance. Computational investigations revealed 
that the access to an oxygen stabilizing pocket in the WT can be triggered by 
substitutions in position 560 and that the access is blocked in V7. Furthermore, MD-
simulations showed that the placed oxygen is leaving not only the reactive position in 
the active site of V7 but the enzyme completely. V7 was successfully evolved to 
operate oxygen independent with a diabetes relevant mediator system (quinone 
diimine/phenylendiamine). The main challenge in diabetes analytics is the 
development of a glucose sensor which operates free from any interference by 
clinical relevant sugars or by oxygen. V7 gives the opportunity to accomplish that 
challenge by the combination of the glucose specificity with a significant reduced 
oxygen dependency. The combination of V7 with well established quinone diimine 
based mediator systems allow an accurate glucose determination in the presence of 
clinical relevant sugars and at high oxygen levels with only one sensor. These 
insights will inspire protein engineers, biofuel cell scientists, clinical researchers and 
bio-process engineers to redesign other GOxs and oxidoreductases to develop 
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implantable biofuel cells (GOx in anodic compartment) and to design more robust 
and accurate glucose monitoring systems.  
In the second project part, the influence of residue 414 on the interaction of small 
soluble mediator compounds and GOx were investigated. A site saturation 
experiment revealed a subset of amino acids (Y, M, L, V) which changed the 
preference of GOx from the QDM-1 to the more polar and sterically more demanding 
QDM-2. The substitution I414Y resulted in a 4.8-fold increased activity of V7 
employing the QDM-2 system, what was traced back to a higher affinity through the 
change to a more polar residue and to structural reorganization. Furthermore, it was 
shown that substitutions of residue 414 also influence the activity employing 
ferrocenemethanol, a prominent mediator example for GOx. Molecular docking 
studies first time showed that small water soluble mediator compounds bind directly 
in the active site of GOx in close vicinity to residue 414. Theoretical calculated 
electron transfer rates (according to the Marcus-Theory) [112] were in good 
accordance with the catalytic data. The analysis of the Marcus-Theory indicated that 
substitutions of residue 414 might change the mediator activity by minimizing the 
molecular reorganization during charge transfer. The mediator study revealed a 
mediator binding model for GOx employing small water soluble mediators. It was 
found that residue 414 is in direct vicinity to the mediator binding site and 
substitutions allow modulating the efficiency of the electron transfer rate. The study 
first time showed the adaption of an enzyme to a specific mediator by protein 
engineering. Furthermore, it reveals the opportunity to combine protein engineering 
with mediator engineering to not only screen for suitable mediators but to adopt 
enzymes to optimal mediator systems for a defined application. This novel approach 
might not only play an important role in diagnostics but also in the field of bio-fuel 
cells in order to adopt electron donor or acceptor enzymes to optimized bio-fuel cell 
setups. 
In the last project part a bio-process was established in order to ensure a fast and 
efficient production of GOx for characterization studies. Media screening and 
investigations of the feeding strategy revealed a batch fermentation process with a 
process time of 48 h. The fermentation process was characterized with respect to 
bio-mass formation, glucose consumption, respiratory properties (RQ, pO2), acetate 
formation and GOx formation. The fermentation process was divided in four phases, 
a lag-phase, two growth phases and an expression phase. Thereby, the best 
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biomass formation was reached in growth phase one with µ=0.4 h-1. The downstream 
process was scaled-up for the handling of 10 to 20 L of cell broth. Tangential flow 
filtration was introduced for the cell harvest (mico-filtration) and product isolation 
(ultra-filtration) in order to handle the respective volumes. The optimization of an 
anion-exchange chromatography step resulted in a downstream process with only 
one purification step. Samples with a GOx-content higher 90 % could be reached. 
The establishment of GOx production protocols resulted in a fast and reproducible 
process, which was successfully employed within characterization studies of GOx 
variants (project part one and two). 
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8. Abbreviations 
 
aa Amino acid 
ABTS 2,2′‐azino‐bis(3‐ethylbenz‐thiazoline‐6‐sulfonic acid) 
AEC Anion-exchange chromatography 
A. niger Aspergillus niger 
bp Base pair 
cfu cell forming unit 
DNA deoxyribonucleic acid 
dNTP deoxynucleoside triphosphate 
E. coli Escherichia coli 
ELISA enzyme-linked immunosorbent assay 
ETR electron transfer rate 
FM ferrocenemethanol 
epPCR error prone polymerase chain reaction 
FAD Flavin adenine dinucleotide 
FWD forward 
FPLC fast liquid chromatographie 
GDH Glucose dehydrogenase 
GOx Glucose oxidase 
HIC hydrophobic interaction chromatography 
HRP horseradish peroxidase 
INV Invitrogen 
MCS multiple cloning site 
MTP micro-titer plate 
OI-ratio Residual activity QDM assay / residual activity ABTS assay 
(Oxygen-Independent GOx ratio) 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
pDNA plasmid-DNA 
PMO phosphomolybdic acid 
pO2 oxygen partial pressure 
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PQQ pyrrolochinolinchinon depending 
QDM chinonediimine based mediator 
REV reverse 
RQ respiratory quotient 
RV Reference variant 
Sc Saccharomyces cerevisiae 
SC-U Saccharomyces cerevisiae media without uracil 
SDS sodium dodecyl sulfate 
SeSaM sequence saturation mutagenesis 
SSM site saturation mutagenesis 
Syn-Y synthetic yeast media 
Taq Thermus aquatcus 
TFF tangential flow filtration 
TS transition 
TV transversion 
UV/VIS ultraviolet / visible 
V variant 
WT wild type 
YPD yeast peptone media 
 
